Amedeo Smart

Free Medical Literature Service



HIV Infection

  Free Subscription

Articles published in
J Virol
    July 2018
  1. MAVIGNER M, Habib J, Deleage C, Rosen E, et al
    SIV persistence in cellular and anatomic reservoirs in ART-suppressed infant rhesus macaques.
    J Virol. 2018 Jul 11. pii: JVI.00562-18. doi: 10.1128/JVI.00562.
    >> Share

  2. CHAN KW, Pan R, Costa M, Gorny MK, et al
    Structural Comparison of Human Anti-HIV-1 gp120 V3 MAbs of the Same Gene Usage Induced by Vaccination and Chronic Infection.
    J Virol. 2018 Jul 11. pii: JVI.00641-18. doi: 10.1128/JVI.00641.
    >> Share

  3. BUFFONE C, Martinez-Lopez A, Fricke T, Opp S, et al
    Nup153 Unlocks the Nuclear Pore Complex for HIV-1 Nuclear Translocation in Non-dividing Cells.
    J Virol. 2018 Jul 11. pii: JVI.00648-18. doi: 10.1128/JVI.00648.
    >> Share

  4. OJWACH DBA, MacMillan D, Reddy T, Novitsky V, et al
    Pol-driven replicative capacity impacts disease progression in HIV-1 subtype C infection.
    J Virol. 2018 Jul 11. pii: JVI.00811-18. doi: 10.1128/JVI.00811.
    >> Share

  5. SCHWARTZ JA, Zhang H, Ende Z, Deymier MJ, et al
    Characterization of the plasmacytoid dendritic cell response to transmitted/founder and non-transmitted variants of HIV-1.
    J Virol. 2018 Jul 11. pii: JVI.00157-18. doi: 10.1128/JVI.00157.
    >> Share

  6. CHIEN H, Alston CI, Dix RD
    Suppressor of Cytokine Signaling (SOCS)1 and SOCS3 Are Stimulated Within the Eye During Experimental Murine Cytomegalovirus Retinitis in Mice With Retrovirus-Induced Immunosuppression.
    J Virol. 2018 Jul 5. pii: JVI.00526-18. doi: 10.1128/JVI.00526.
    >> Share

  7. KHAN SN, Sok D, Tran K, Movsesyan A, et al
    Targeting the HIV-1 spike and co-receptor with bi- and trispecific antibodies for single-component broad inhibition of entry.
    J Virol. 2018 Jul 5. pii: JVI.00384-18. doi: 10.1128/JVI.00384.
    >> Share

  8. HOVANESSIAN AG, Soundaramourty C, Benferhat R, Le Grand R, et al
    Vaccination with the conserved caveolin-1 binding motif in HIV-1 glycoprotein gp41 delays the onset of viral infection and provides partial protection in SHIV-challenged cynomolgus macaques.
    J Virol. 2018 Jul 5. pii: JVI.00370-18. doi: 10.1128/JVI.00370.
    >> Share

  9. NOTO A, Procopio FA, Banga R, Suffiotti M, et al
    CD32(+) and PD-1(+) Lymph Node CD4 T Cells Support Persistent HIV-1 Transcription in Treated Aviremic Individuals.
    J Virol. 2018 Jul 5. pii: JVI.00901-18. doi: 10.1128/JVI.00901.
    >> Share

  10. HEUSINGER E, Deppe K, Sette P, Krapp C, et al
    Preadaptation of SIVsmm facilitated Env-mediated counteraction of human tetherin by HIV-2.
    J Virol. 2018 Jul 5. pii: JVI.00276-18. doi: 10.1128/JVI.00276.
    >> Share

  11. YAN Q, Zhao R, Shen C, Wang F, et al
    Upregulation of miR-711 mediates HIV-1 Vpr promotion of KSHV latency and induction of pro-proliferative/survival cytokines by targeting the Notch/NF-kappaB signaling axis.
    J Virol. 2018 Jul 5. pii: JVI.00580-18. doi: 10.1128/JVI.00580.
    >> Share

    June 2018
  12. DITSE Z, Muenchhoff M, Adland E, Jooste P, et al
    J Virol. 2018 Jun 27. pii: JVI.00878-18. doi: 10.1128/JVI.00878.
    >> Share

  13. SCHILLING M, Bulli L, Weigang S, Graf L, et al
    Human MxB protein is a pan-herpesvirus restriction factor.
    J Virol. 2018 Jun 27. pii: JVI.01056-18. doi: 10.1128/JVI.01056.
    >> Share

  14. BROCCA-COFANO E, Xu C, Wetzel KS, Cottrell ML, et al
    Marginal Effects of Systemic CCR5 Blockade with Maraviroc on Oral Simian Immunodeficiency Virus Transmission to Infant Macaques.
    J Virol. 2018 Jun 20. pii: JVI.00576-18. doi: 10.1128/JVI.00576.
    >> Share

  15. XU B, Pan Q, Liang C
    The role of MxB in interferon-alpha mediated inhibition of HIV-1 infection.
    J Virol. 2018 Jun 20. pii: JVI.00422-18. doi: 10.1128/JVI.00422.
    >> Share

  16. MULLER JA, Glockle A, Gawanbacht A, Geyer M, et al
    Reduced Susceptibility to VIRIP-based HIV-1 Entry Inhibitors has a High Genetic Barrier and Severe Fitness Costs.
    J Virol. 2018 Jun 20. pii: JVI.00733-18. doi: 10.1128/JVI.00733.
    >> Share

  17. CHONG H, Xue J, Zhu Y, Cong Z, et al
    Design of Novel HIV-1/2 Fusion Inhibitors with Efficient Therapeutic Efficacy in Rhesus Monkey Models.
    J Virol. 2018 Jun 13. pii: JVI.00775-18. doi: 10.1128/JVI.00775.
    >> Share

    Cross-Reactivity Against Multiple HIV-1 Epitopes Is Characteristic of HIV-1-Specific Cytotoxic T Lymphocyte Clones.
    J Virol. 2018 Jun 13. pii: JVI.00617-18. doi: 10.1128/JVI.00617.
    >> Share

  19. DHARAN A, Campbell EM
    The Role of Microtubules and Microtubule Associated Proteins in HIV-1 Infection.
    J Virol. 2018 Jun 13. pii: JVI.00085-18. doi: 10.1128/JVI.00085.
    >> Share

  20. GURUNG S, Preno AN, Dubaut JP, Nadeau H, et al
    Translational Model of Zika Virus Disease in Baboons.
    J Virol. 2018 Jun 6. pii: JVI.00186-18. doi: 10.1128/JVI.00186.
    >> Share

  21. KELLER PW, Morrison O, Vassell R, Weiss CD, et al
    HIV-1 gp41 Residues Modulate CD4-Induced Conformational Changes in the Envelope Glycoprotein and Evolution of a Relaxed Conformation of gp120.
    J Virol. 2018 Jun 6. pii: JVI.00583-18. doi: 10.1128/JVI.00583.
    >> Share

  22. NEVOT M, Jordan-Paiz A, Martrus G, Andres C, et al
    HIV-1 Protease Evolvability is Affected by Synonymous Nucleotide Recoding.
    J Virol. 2018 Jun 6. pii: JVI.00777-18. doi: 10.1128/JVI.00777.
    >> Share

  23. MARTINS MA, Tully DC, Pedreno-Lopez N, von Bredow B, et al
    Mamu-B*17+ rhesus macaques vaccinated with env, vif, and nef manifest early control of SIVmac239 replication.
    J Virol. 2018 Jun 6. pii: JVI.00690-18. doi: 10.1128/JVI.00690.
    >> Share

    May 2018
  24. ANTONUCCI JM, Kim SH, St Gelais C, Bonifati S, et al
    SAMHD1 Impairs HIV-1 Gene Expression and Negatively Modulates Reactivation of Viral Latency in CD4(+) T-cells.
    J Virol. 2018 May 23. pii: JVI.00292-18. doi: 10.1128/JVI.00292.
    >> Share

  25. SINGH S, Ramirez-Salazar EG, Doueiri R, Valentin A, et al
    Control of Heterologous SIVsmE660 infection by DNA and Protein Co-immunization Regimens Combined with Different Toll-like Receptor-4 (TLR-4) Based Adjuvants in Macaques.
    J Virol. 2018 May 23. pii: JVI.00281-18. doi: 10.1128/JVI.00281.
    >> Share

  26. KANG ZH, Bricault CA, Borducchi EN, Stephenson KE, et al
    Similar epitope specificities of IgG and IgA antibodies elicited by Ad26 vector prime, Env protein boost immunizations in rhesus monkeys.
    J Virol. 2018 May 23. pii: JVI.00537-18. doi: 10.1128/JVI.00537.
    >> Share

  27. BAIYEGUNHI O, Ndlovu B, Ogunshola F, Ismail N, et al
    Frequencies of circulating Th1-biased T follicular helper cells in acute HIV-1 infection correlate with the development of HIV-specific antibody responses and lower set point viral load.
    J Virol. 2018 May 23. pii: JVI.00659-18. doi: 10.1128/JVI.00659.
    >> Share

  28. CAREY BD, Ammosova T, Pinkham C, Lin X, et al
    Protein Phosphatase 1alpha Interacts with Venezuelan Equine Encephalitis Virus Capsid Protein and Regulates Viral Replication through Modulation of Capsid Phosphorylation.
    J Virol. 2018 May 16. pii: JVI.02068-17. doi: 10.1128/JVI.02068.
    >> Share

  29. KUMAR S, Morrison JH, Dingli D, Poeschla E, et al
    HIV-1 activation of innate immunity depends strongly on the intracellular level of TREX1 and sensing of incomplete reverse transcription products.
    J Virol. 2018 May 16. pii: JVI.00001-18. doi: 10.1128/JVI.00001.
    >> Share

  30. JI S, Na L, Ren H, Wang Y, et al
    Equine Myxovirus Resistance Protein 2 Restricts Lentiviral Replication by Blocking Nuclear Uptake of Capsid Protein.
    J Virol. 2018 May 9. pii: JVI.00499-18. doi: 10.1128/JVI.00499.
    >> Share

  31. ELSAYED H, Nabi G, McKinstry WJ, Khoo KK, et al
    Intrastructural Help: Harnessing T-Helper Cells Induced by Licensed Vaccines for Improvement of HIV Env Antibody Responses to Virus-Like Particle Vaccines.
    J Virol. 2018 May 9. pii: JVI.00141-18. doi: 10.1128/JVI.00141.
    >> Share

  32. QIAO J, Cao Y, Zabaleta J, Yang L, et al
    Regulation of virus-associated lymphoma growth and gene expression by bacterial quorum sensing molecules.
    J Virol. 2018 May 9. pii: JVI.00478-18. doi: 10.1128/JVI.00478.
    >> Share

  33. SCINTO HB, Gupta S, Thorat S, Mukhtar MM, et al
    A novel strategy to adapt SHIV-E1 carrying env from an RV144 volunteer to rhesus macaques: coreceptor switch and final recovery of a pathogenic virus with exclusive R5 tropism.
    J Virol. 2018 May 9. pii: JVI.02222-17. doi: 10.1128/JVI.02222.
    >> Share

  34. LODERMEYER V, Ssebyatika G, Passos V, Ponnurangam A, et al
    The Antiviral Activity of the Cellular Glycoprotein LGALS3BP/90K is Species-Specific.
    J Virol. 2018 May 9. pii: JVI.00226-18. doi: 10.1128/JVI.00226.
    >> Share

  35. MUELLER N, Pasternak AO, Klaver B, Cornelissen M, et al
    The HIV-1 Tat protein enhances splicing at the major splice donor site.
    J Virol. 2018 May 9. pii: JVI.01855-17. doi: 10.1128/JVI.01855.
    >> Share

  36. WENSEL D, Sun Y, Davis J, Li Z, et al
    A Novel gp41-Binding Adnectin with Potent Anti-HIV Activity Is Highly Synergistic when Linked to a CD4-Binding Adnectin.
    J Virol. 2018 May 9. pii: JVI.00421-18. doi: 10.1128/JVI.00421.
    >> Share

  37. MAHDI M, Szojka Z, Motyan JA, Tozser J, et al
    Inhibitory effects of HIV-2 Vpx on replication of HIV-1.
    J Virol. 2018 May 9. pii: JVI.00554-18. doi: 10.1128/JVI.00554.
    >> Share

  38. PALESCH D, Bosinger SE, Mavigner M, Billingsley JM, et al
    Short-term pIFN-alpha2a treatment does not significantly reduce the viral reservoir of SIV-infected, ART-treated rhesus macaques.
    J Virol. 2018 May 2. pii: JVI.00279-18. doi: 10.1128/JVI.00279.
    >> Share

  39. BROZY J, Schlaepfer E, Mueller CKS, Rochat MA, et al
    Antiviral Activity of HIV gp120 Targeting Bispecific T Cell Engager (BiTE(R)) Antibody Constructs.
    J Virol. 2018 May 2. pii: JVI.00491-18. doi: 10.1128/JVI.00491.
    >> Share

  40. HOUZET L, Perez-Losada M, Matusali G, Deleage C, et al
    Seminal SIV in chronically-infected cynomolgus macaques is dominated by virus originating from multiple genital organs.
    J Virol. 2018 May 2. pii: JVI.00133-18. doi: 10.1128/JVI.00133.
    >> Share

  41. ANTHONY C, York T, Bekker V, Matten D, et al
    Correction for Anthony et al., "Cooperation between Strain-Specific and Broadly Neutralizing Responses Limited Viral Escape and Prolonged the Exposure of the Broadly Neutralizing Epitope".
    J Virol. 2018;92.
    >> Share

    April 2018
  42. MARTIN JL, Mendonca L, Marusinec R, Zuczek J, et al
    Critical Role of the HTLV-1 Capsid N-Terminal Domain for Gag-Gag Interactions and Virus Particle Assembly.
    J Virol. 2018 Apr 25. pii: JVI.00333-18. doi: 10.1128/JVI.00333.
    >> Share

  43. OZOROWSKI G, Cupo A, Golabek M, LoPiccolo M, et al
    Effects of adjuvants on HIV-1 envelope glycoprotein SOSIP trimers in vitro.
    J Virol. 2018 Apr 18. pii: JVI.00381-18. doi: 10.1128/JVI.00381.
    >> Share

  44. PAPARISTO E, Woods MW, Coleman MD, Moghadasi SA, et al
    Evolution-guided structural and functional analyses of the HERC family reveals an ancient marine origin and determinants of antiviral activity.
    J Virol. 2018 Apr 18. pii: JVI.00528-18. doi: 10.1128/JVI.00528.
    >> Share

  45. PREVOST J, Richard J, Medjahed H, Alexander A, et al
    Incomplete downregulation of CD4 expression affects HIV-1 Env conformation and ADCC responses.
    J Virol. 2018 Apr 18. pii: JVI.00484-18. doi: 10.1128/JVI.00484.
    >> Share

  46. BRICAULT CA, Kovacs JM, Badamchi-Zadeh A, McKee K, et al
    Neutralizing Antibody Responses following Long-Term Vaccination with HIV-1 Env gp140 in Guinea Pigs.
    J Virol. 2018 Apr 11. pii: JVI.00369-18. doi: 10.1128/JVI.00369.
    >> Share

  47. REZAEI SD, Lu HK, Chang JJ, Rhodes A, et al
    The pathway to establishing HIV latency is critical to how latency is maintained and reversed.
    J Virol. 2018 Apr 11. pii: JVI.02225-17. doi: 10.1128/JVI.02225.
    >> Share

  48. POLICICCHIO BB, Cardozo EF, Sette P, Xu C, et al
    The dynamics of SIV 2-LTR Circles in the Presence and Absence of CD8(+) Cells.
    J Virol. 2018 Apr 11. pii: JVI.02100-17. doi: 10.1128/JVI.02100.
    >> Share

  49. LUO X, Yang W, Gao G
    SUN1 regulates HIV-1 nuclear import in a manner dependent on the interaction between the viral capsid and cellular cyclophilin A.
    J Virol. 2018 Apr 11. pii: JVI.00229-18. doi: 10.1128/JVI.00229.
    >> Share

  50. DELUCIA DC, Rinaldo CR, Rappocciolo G
    Inefficient HIV-1 trans infection of CD4(+) T cells by macrophages from HIV-1 nonprogressors is associated with altered membrane cholesterol and DC-SIGN.
    J Virol. 2018 Apr 11. pii: JVI.00092-18. doi: 10.1128/JVI.00092.
    >> Share

  51. NING J, Zhong Z, Fischer DK, Harris G, et al
    Truncated CPSF6 forms higher order complexes that bind and disrupt HIV-1 capsid.
    J Virol. 2018 Apr 11. pii: JVI.00368-18. doi: 10.1128/JVI.00368.
    >> Share

  52. NATESAMPILLAI S, Cummins NW, Nie Z, Sampath R, et al
    The proapoptotic, HIV protease generated Casp8p41 when bound and inactivated by Bcl2, is degraded by the proteasome.
    J Virol. 2018 Apr 11. pii: JVI.00037-18. doi: 10.1128/JVI.00037.
    >> Share

  53. BOYER PL, Smith SJ, Zhao XZ, Das K, et al
    Developing and evaluating inhibitors against the RNase H active site of HIV-1 RT.
    J Virol. 2018 Apr 11. pii: JVI.02203-17. doi: 10.1128/JVI.02203.
    >> Share

  54. WANG J, Shaban NM, Land AM, Brown WL, et al
    SIVmac239 Vif and Human APOBEC3B Interactions Resemble Those Between HIV-1 Vif and Human APOBEC3G.
    J Virol. 2018 Apr 4. pii: JVI.00447-18. doi: 10.1128/JVI.00447.
    >> Share

  55. SHENOY A, Dwork A, Elkind MSV, Marshall R, et al
    Brain large artery lymphocytic inflammation and Human Immunodeficiency Virus-related brain arterial remodeling.
    J Virol. 2018 Apr 4. pii: JVI.00081-18. doi: 10.1128/JVI.00081.
    >> Share

  56. MOYO T, Ereno-Orbea J, Jacob RA, Pavillet CE, et al
    Molecular basis of unusually high neutralization resistance in tier 3 HIV-1 strain 253-11.
    J Virol. 2018 Apr 4. pii: JVI.02261-17. doi: 10.1128/JVI.02261.
    >> Share

  57. CASTILLO-MENENDEZ LR, Witt K, Espy N, Princiotto A, et al
    Comparison of Uncleaved and Mature Human Immunodeficiency Virus (HIV-1) Membrane Envelope Glycoprotein Trimers.
    J Virol. 2018 Apr 4. pii: JVI.00277-18. doi: 10.1128/JVI.00277.
    >> Share

    March 2018
  58. FETZER I, Gardner MR, Davis-Gardner ME, Prasad NR, et al
    eCD4-Ig variants that more potently neutralize HIV-1.
    J Virol. 2018 Mar 28. pii: JVI.02011-17. doi: 10.1128/JVI.02011.
    >> Share

  59. STRONGIN Z, Sharaf R, VanBelzen DJ, Jacobson JM, et al
    J Virol. 2018 Mar 28. pii: JVI.00285-18. doi: 10.1128/JVI.00285.
    >> Share

  60. HARKER JA, Wong KA, Dallari S, Bao P, et al
    IL-27R signalling mediates early viral containment and impacts innate and adaptive immunity after chronic lymphocytic choriomeningitis virus infection.
    J Virol. 2018 Mar 28. pii: JVI.02196-17. doi: 10.1128/JVI.02196.
    >> Share

  61. SALGADO M, Garcia-Minambres A, Dalmau J, Jimenez-Moyano E, et al
    Control of HIV-1 pathogenesis in viremic nonprogressors is independent of Gag-specific CTL responses.
    J Virol. 2018 Mar 28. pii: JVI.00346-18. doi: 10.1128/JVI.00346.
    >> Share

  62. GARRIDO C, Abad-Fernandez M, Tuyishime M, Pollara JJ, et al
    J Virol. 2018 Mar 28. pii: JVI.00235-18. doi: 10.1128/JVI.00235.
    >> Share

  63. HSU DC, Sunyakumthorn P, Wegner M, Schuetz A, et al
    Central Nervous System Inflammation and Infection During Early, Non-Accelerated Simian-Human Immunodeficiency Virus Infection in Rhesus Macaques.
    J Virol. 2018 Mar 21. pii: JVI.00222-18. doi: 10.1128/JVI.00222.
    >> Share

  64. CASCAJERO A, Rastrojo A, Diez-Fuertes F, Hernandez-Novoa B, et al
    Deep-Sequencing Analysis of the Dynamics of HIV-1 Quasiespecies in Naive Patients during a Short Exposure to Maraviroc.
    J Virol. 2018 Mar 21. pii: JVI.00390-18. doi: 10.1128/JVI.00390.
    >> Share

  65. HESSELL AJ, Shapiro MB, Powell R, Malherbe DC, et al
    Reduced cell-associated DNA and improved viral control in macaques following passive transfer of a single anti-V2 monoclonal antibody and repeated SHIV challenges.
    J Virol. 2018 Mar 7. pii: JVI.02198-17. doi: 10.1128/JVI.02198.
    >> Share

  66. KRISTENSEN AB, Kent SJ, Parsons MS
    Contribution of NK cell education to both direct and anti-HIV-1 antibody-dependent NK cell functions.
    J Virol. 2018 Mar 7. pii: JVI.02146-17. doi: 10.1128/JVI.02146.
    >> Share

  67. SHI J, Xiong R, Zhou T, Su P, et al
    HIV-1 Nef antagonizes SERINC5 restriction by downregulation of SERINC5 via the endosome/lysosome system.
    J Virol. 2018 Mar 7. pii: JVI.00196-18. doi: 10.1128/JVI.00196.
    >> Share

    February 2018
  68. PANASIUK M, Rychlowski M, Derewonko N, Bienkowska-Szewczyk K, et al
    Tunneling nanotubes (TNT) as a novel route of cell-to-cell spread of herpesviruses.
    J Virol. 2018 Feb 28. pii: JVI.00090-18. doi: 10.1128/JVI.00090.
    >> Share

  69. HUAN C, Li Z, Ning S, Wang H, et al
    Long non-coding RNA uc002yug.2 activates HIV-1 latency through regulating mRNA level of various RUNX1 isoforms and increasing Tat expression.
    J Virol. 2018 Feb 28. pii: JVI.01844-17. doi: 10.1128/JVI.01844.
    >> Share

  70. CARNATHAN DG, Mackel JJ, Sweat SL, Enemuo CA, et al
    Intragastric administration of Lactobacillus plantarum and AT-2-inactivated SIV does not protect Indian rhesus macaques from intra-rectal SIV challenge nor reduce virus replication after transmission.
    J Virol. 2018 Feb 28. pii: JVI.02030-17. doi: 10.1128/JVI.02030.
    >> Share

  71. ASHOKKUMAR M, Aralaguppe SG, Tripathy SP, Hanna LE, et al
    Unique phenotypic characteristics of recently transmitted HIV-1 subtype C envelope glycoprotein gp120: Use of CXCR6 co-receptor by transmitted founder viruses.
    J Virol. 2018 Feb 28. pii: JVI.00063-18. doi: 10.1128/JVI.00063.
    >> Share

  72. REED JC, Westergreen N, Barajas BC, Ressler DTB, et al
    The formation of RNA granule-derived capsid assembly intermediates appears to be conserved between HIV-1 and the non-primate lentivirus FIV.
    J Virol. 2018 Feb 21. pii: JVI.01761-17. doi: 10.1128/JVI.01761.
    >> Share

  73. CARNATHAN D, Lawson B, Yu J, Patel K, et al
    Reduced chronic lymphocyte activation following Interferon-alpha blockade in the acute phase of SIV infection in rhesus macaques.
    J Virol. 2018 Feb 21. pii: JVI.01760-17. doi: 10.1128/JVI.01760.
    >> Share

  74. WANG C, Zhou H, Xue Y, Liang J, et al
    Epstein-Barr Virus Nuclear Antigen Leader protein co-activates EP300.
    J Virol. 2018 Feb 21. pii: JVI.02155-17. doi: 10.1128/JVI.02155.
    >> Share

  75. MADRID-ELENA N, Garcia-Bermejo ML, Serrano-Villar S, Diaz-de Santiago A, et al
    Maraviroc is associated with latent HIV-1 reactivation through NF-kappaB activation in resting CD4(+) T cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy.
    J Virol. 2018 Feb 14. pii: JVI.01931-17. doi: 10.1128/JVI.01931.
    >> Share

  76. SAUNDERS KO, Santra S, Parks R, Yates NL, et al
    Immunogenicity of NYVAC prime-protein boost HIV-1 envelope vaccination and SHIV challenge of nonhuman primates.
    J Virol. 2018 Feb 7. pii: JVI.02035-17. doi: 10.1128/JVI.02035.
    >> Share

  77. BIRYUKOV J, Meyers C
    Superinfection Exclusion between Two High-Risk Human Papillomavirus (HPV) Types During a Co-Infection.
    J Virol. 2018 Feb 7. pii: JVI.01993-17. doi: 10.1128/JVI.01993.
    >> Share

    January 2018
  78. CHEUNG KW, Wu T, Ho SF, Wong YC, et al
    alpha4beta7(+) CD4(+) effector/effector memory T cells differentiate into productively and latently infected central memory T cells by TGFbeta1 during HIV-1 infection.
    J Virol. 2018 Jan 31. pii: JVI.01510-17. doi: 10.1128/JVI.01510.
    >> Share

  79. YATES NL, deCamp AC, Korber BT, Liao HX, et al
    HIV-1 Envelope Glycoproteins from Diverse Clades Differentiate Antibody Responses and Durability among Vaccinees.
    J Virol. 2018 Jan 31. pii: JVI.01843-17. doi: 10.1128/JVI.01843.
    >> Share

  80. RUJAS E, Leaman DP, Insausti S, Ortigosa-Pascual L, et al
    J Virol. 2018 Jan 31. pii: JVI.02249-17. doi: 10.1128/JVI.02249.
    >> Share

    Defining the barriers to women publishing in high-impact journals.
    J Virol. 2018 Jan 24. pii: JVI.02127-17. doi: 10.1128/JVI.02127.
    >> Share

  82. TORRENTS DE LA PENA A, de Taeye SW, Sliepen K, LaBranche CC, et al
    Immunogenicity in rabbits of SOSIP trimers from clades A, B and C, given individually, sequentially or in combinations.
    J Virol. 2018 Jan 24. pii: JVI.01957-17. doi: 10.1128/JVI.01957.
    >> Share

  83. SATHEESAN S, Li H, Burnett JC, Takahashi M, et al
    HIV replication and latency in a humanized NSG mouse model during suppressive oral combinational ART.
    J Virol. 2018 Jan 17. pii: JVI.02118-17. doi: 10.1128/JVI.02118.
    >> Share

  84. ABNER E, Stoszko M, Zeng L, Chen HC, et al
    A new quinoline BRD4 inhibitor targets a distinct latent HIV-1 reservoir for re-activation from other 'shock' drugs.
    J Virol. 2018 Jan 17. pii: JVI.02056-17. doi: 10.1128/JVI.02056.
    >> Share

  85. PAN R, Qin Y, Banasik M, Lees W, et al
    Increased epitope complexity correlated with antibody affinity maturation and a novel binding mode revealed by structures of rabbit antibodies against the third variable loop (V3) of HIV-1 gp120.
    J Virol. 2018 Jan 17. pii: JVI.01894-17. doi: 10.1128/JVI.01894.
    >> Share

  86. ITA S, Hill AK, Lam EC, Dufort FJ, et al
    High-Resolution Sequencing of Viral Populations During Early SIV Infection Reveals Evolutionary Strategies for Rapid Escape from Emerging Env-Specific Antibody Responses.
    J Virol. 2018 Jan 17. pii: JVI.01574-17. doi: 10.1128/JVI.01574.
    >> Share

  87. WU X, Liu Z, Ding X, Yu D, et al
    Mechanism of HIV-1 Resistance to an Electronically Constrained alpha-Helical Peptide Membrane Fusion Inhibitor.
    J Virol. 2018 Jan 10. pii: JVI.02044-17. doi: 10.1128/JVI.02044.
    >> Share

  88. MISRA A, Gleeson E, Wang W, Ye C, et al
    Glycosyl-phosphatidylinositol-Anchored Anti-HIV Env Single Chain Variable Fragments Interfere with HIV-1 Env Processing and Viral Infectivity.
    J Virol. 2018 Jan 10. pii: JVI.02080-17. doi: 10.1128/JVI.02080.
    >> Share

  89. ST GELAIS C, Kim SH, Maksimova VV, Buzovetsky O, et al
    A Cyclin-binding Motif in Human SAMHD1 Is Required for Its HIV-1 Restriction, dNTPase Activity, Tetramer Formation, and Efficient Phosphorylation.
    J Virol. 2018 Jan 10. pii: JVI.01787-17. doi: 10.1128/JVI.01787.
    >> Share

  90. EVANS EL 3RD, Becker JT, Fricke SL, Patel K, et al
    HIV-1 Vif's capacity to manipulate the cell cycle is species-specific.
    J Virol. 2018 Jan 10. pii: JVI.02102-17. doi: 10.1128/JVI.02102.
    >> Share

  91. WILLS S, Hwang KK, Liu P, Dennison SM, et al
    HIV-1 specific IgA Monoclonal Antibodies from an HIV-1 Vaccinee Mediate Galcer Blocking and Phagocytosis.
    J Virol. 2018 Jan 10. pii: JVI.01552-17. doi: 10.1128/JVI.01552.
    >> Share

  92. ENDE Z, Deymier MJ, Claiborne DT, Prince JL, et al
    HLA Class I Downregulation by HIV-1 Variants from Subtype C Transmission Pairs.
    J Virol. 2018 Jan 10. pii: JVI.01633-17. doi: 10.1128/JVI.01633.
    >> Share

  93. BADAMCHI-ZADEH A, Tartaglia LJ, Abbink P, Bricault CA, et al
    Therapeutic efficacy of vectored PGT121 gene delivery in HIV-1-infected humanized mice.
    J Virol. 2018 Jan 10. pii: JVI.01925-17. doi: 10.1128/JVI.01925.
    >> Share

  94. ZAIKOS TD, Painter MM, Sebastian NT, Terry VH, et al
    Class 1-selective histone deacetylase inhibitors enhance HIV latency reversal while preserving the activity of HDAC isoforms necessary for maximal HIV gene expression.
    J Virol. 2018 Jan 3. pii: JVI.02110-17. doi: 10.1128/JVI.02110.
    >> Share

  95. HRABER P, Rademeyer C, Williamson C, Seaman MS, et al
    Correction for Hraber et al., "Panels of HIV-1 Subtype C Env Reference Strains for Standardized Neutralization Assessments".
    J Virol. 2017;92.
    >> Share

    December 2017
  96. GU Q, Zhang Z, Gertzen CGW, Haussinger D, et al
    Identification of a conserved interface of HIV-1 and FIV Vifs with Cullin 5.
    J Virol. 2017 Dec 20. pii: JVI.01697-17. doi: 10.1128/JVI.01697.
    >> Share

  97. ZHOU R, Wang X, Liu H, Guo L, et al
    GalNAc-Specific Soybean Lectin Inhibits HIV Infection of Macrophages through Induction of Antiviral Factors.
    J Virol. 2017 Dec 20. pii: JVI.01720-17. doi: 10.1128/JVI.01720.
    >> Share

  98. LIANG R, Sun Y, Liu Y, Wang J, et al
    Major histocompatibility complex class I (FLA-E*01801) molecular structure in domestic cats demonstrates species-specific characteristics in presenting viral antigen peptides.
    J Virol. 2017 Dec 20. pii: JVI.01631-17. doi: 10.1128/JVI.01631.
    >> Share

  99. FRICKE T, Brandariz-Nunez A, Wang X, Smith AB 3rd, et al
    Correction for Fricke et al., "Human Cytosolic Extracts Stabilize the HIV-1 Core".
    J Virol. 2017;91.
    >> Share

  100. JONES AT, Chamcha V, Kesavardhana S, Shen X, et al
    A trimeric HIV-1 envelope gp120 immunogen induces potent and broad anti-V1V2 loop antibodies against HIV-1 in rabbits and rhesus macaques.
    J Virol. 2017 Dec 13. pii: JVI.01796-17. doi: 10.1128/JVI.01796.
    >> Share

  101. MORGER D, Zosel F, Buhlmann M, Zuger S, et al
    The three-fold axis of the HIV-1 capsid lattice is the species-specific binding interface for TRIM5alpha.
    J Virol. 2017 Dec 13. pii: JVI.01541-17. doi: 10.1128/JVI.01541.
    >> Share

  102. CHIKATA T, Van Tran G, Murakoshi H, Akahoshi T, et al
    HLA class I-mediated HIV-1 control in Vietnamese infected with HIV-1 subtype A/E.
    J Virol. 2017 Dec 13. pii: JVI.01749-17. doi: 10.1128/JVI.01749.
    >> Share

  103. COHEN YZ, Lorenzi JCC, Seaman MS, Nogueira L, et al
    Neutralizing activity of broadly neutralizing anti-HIV-1 antibodies against clade B clinical isolates produced in peripheral blood mononuclear cells.
    J Virol. 2017 Dec 13. pii: JVI.01883-17. doi: 10.1128/JVI.01883.
    >> Share

  104. SCHOUEST B, Weiler AM, Janaka SK, Myers TA, et al
    Maintenance of AP-2 Dependent Functional Activities of Nef Restricts Pathways of Immune Escape from CD8 T Lymphocyte Responses.
    J Virol. 2017 Dec 13. pii: JVI.01822-17. doi: 10.1128/JVI.01822.
    >> Share

  105. QUALLS ZM, Choudhary A, Honnen W, Prattipati R, et al
    Identification of novel structural determinants in MW965 Env that regulate the neutralization phenotype and conformational masking potential of primary HIV-1 isolates.
    J Virol. 2017 Dec 13. pii: JVI.01779-17. doi: 10.1128/JVI.01779.
    >> Share

  106. PERNAS M, Tarancon-Diez L, Rodriguez-Gallego E, Gomez J, et al
    Factors Leading to the Loss of Natural Elite Control of HIV-1 Infection.
    J Virol. 2017 Dec 6. pii: JVI.01805-17. doi: 10.1128/JVI.01805.
    >> Share

  107. KIRSCHMAN J, Qi M, Ding L, Hammonds J, et al
    HIV-1 Envelope Glycoprotein Trafficking through the Endosomal Recycling Compartment is Required for Particle Incorporation.
    J Virol. 2017 Dec 6. pii: JVI.01893-17. doi: 10.1128/JVI.01893.
    >> Share

  108. SATO K, Misawa N, Takeuchi JS, Kobayashi T, et al
    Experimental adaptive evolution of SIVcpz to pandemic HIV-1 using a humanized mouse model.
    J Virol. 2017 Dec 6. pii: JVI.01905-17. doi: 10.1128/JVI.01905.
    >> Share

  109. YOON CH, Kim SY, Byeon SE, Jeong Y, et al
    Correction for Yoon et al., "p53-Derived Host Restriction of HIV-1 Replication by Protein Kinase R-Mediated Tat Phosphorylation and Inactivation".
    J Virol. 2017;91.
    >> Share

    November 2017
  110. DE VERNEUIL A, Migraine J, Mammano F, Molina JM, et al
    Genetically intact but functionally impaired HIV-1 Env glycoproteins in the T-cell reservoir.
    J Virol. 2017 Nov 29. pii: JVI.01684-17. doi: 10.1128/JVI.01684.
    >> Share

  111. WAGNER JM, Christensen DE, Bhattacharya A, Dawidziak DM, et al
    A general model for retroviral capsid pattern recognition by TRIM5 proteins.
    J Virol. 2017 Nov 29. pii: JVI.01563-17. doi: 10.1128/JVI.01563.
    >> Share

  112. ADLAND E, Hill M, Lavandier N, Csala A, et al
    J Virol. 2017 Nov 22. pii: JVI.01685-17. doi: 10.1128/JVI.01685.
    >> Share

  113. CHAILLON A, Gianella S, Lada SM, Perez-Santiago J, et al
    Size, Composition, and Evolution of HIV DNA Populations during Early Antiretroviral Therapy and Intensification with Maraviroc.
    J Virol. 2017 Nov 15. pii: JVI.01589-17. doi: 10.1128/JVI.01589.
    >> Share

  114. WHITE E, Wu F, Chertova E, Bess J, et al
    Truncating the Gp41 Cytoplasmic Tail of SIV Decreases Sensitivity to Neutralizing Antibodies without Increasing Envelope Content of Virions.
    J Virol. 2017 Nov 15. pii: JVI.01688-17. doi: 10.1128/JVI.01688.
    >> Share

  115. ELLIS-CONNELL AL, Balgeman AJ, Zarbock KR, Barry G, et al
    ALT-803 transiently reduces SIV replication in the absence of antiretroviral treatment.
    J Virol. 2017 Nov 8. pii: JVI.01748-17. doi: 10.1128/JVI.01748.
    >> Share

  116. PINKEVYCH M, Fennessey CM, Cromer D, Tolstrup M, et al
    Estimating initial viral levels during HIV/SIV reactivation from latency.
    J Virol. 2017 Nov 8. pii: JVI.01667-17. doi: 10.1128/JVI.01667.
    >> Share

  117. QUITADAMO B, Peters PJ, Repik A, O'Connell O, et al
    HIV-1 R5 macrophage-tropic envelope glycoprotein trimers bind CD4 with high affinity, while the CD4 binding site on non-macrophage-tropic, T- tropic R5 envelopes is occluded.
    J Virol. 2017 Nov 8. pii: JVI.00841-17. doi: 10.1128/JVI.00841.
    >> Share

  118. SOTO-NAVA M, Avila-Rios S, Valenzuela-Ponce H, Garcia-Morales C, et al
    Weaker HLA footprints on HIV in the unique and highly genetically admixed host population of Mexico.
    J Virol. 2017 Nov 1. pii: JVI.01128-17. doi: 10.1128/JVI.01128.
    >> Share

  119. MALHERBE DC, Mendy J, Vang L, Barnette PT, et al
    Combination Adenovirus and Protein Vaccines Prevent Infection or Reduce Viral Burden after Heterologous Clade C SHIV Mucosal Challenge.
    J Virol. 2017 Nov 1. pii: JVI.01092-17. doi: 10.1128/JVI.01092.
    >> Share

  120. PAYNE EH, Ramalingam D, Fox DT, Klotman ME, et al
    Polyploidy And Mitotic Cell Death Are Two Distinct HIV-1 Vpr-Driven Outcomes In Renal Tubule Epithelial Cells.
    J Virol. 2017 Nov 1. pii: JVI.01718-17. doi: 10.1128/JVI.01718.
    >> Share

  121. ARACHCHIGE SP, Henke W, Pramanik A, Kalamvoki M, et al
    Analysis of Select HSV-1 Proteins for Restriction of Human Immunodeficiency Virus Type 1: The HSV-1 gM Protein Potently Restricts HIV-1 by Preventing the Intracellular Transport and Processing of Env gp160.
    J Virol. 2017 Nov 1. pii: JVI.01476-17. doi: 10.1128/JVI.01476.
    >> Share

    October 2017
  122. PAROLINI F, Biswas P, Serena M, Sironi F, et al
    Stability and expression levels of HLA-C on the cell membrane modulate HIV-1 infectivity.
    J Virol. 2017 Oct 25. pii: JVI.01711-17. doi: 10.1128/JVI.01711.
    >> Share

  123. KASMAPOUR B, Kubsch T, Rand U, Eiz-Vesper B, et al
    Myeloid dendritic cells repress human cytomegalovirus gene expression and spread by releasing interferon-unrelated soluble antiviral factors.
    J Virol. 2017 Oct 18. pii: JVI.01138-17. doi: 10.1128/JVI.01138.
    >> Share

  124. YOUNG GR, Terry SN, Manganaro L, Cuesta-Dominguez A, et al
    HIV-1 infection of primary CD4+ T cells regulates the expression of specific HERV-K (HML-2) elements.
    J Virol. 2017 Oct 18. pii: JVI.01507-17. doi: 10.1128/JVI.01507.
    >> Share

  125. MWIMANZI F, Toyoda M, Mahiti M, Mann JK, et al
    Relative resistance of MHC-B to Nef-mediated downregulation is conserved among primate lentiviruses and influences antiviral T cell responses in HIV-1-infected individuals.
    J Virol. 2017 Oct 18. pii: JVI.01409-17. doi: 10.1128/JVI.01409.
    >> Share

  126. MCGUIRE EP, Fong Y, Toote C, Cunningham CK, et al
    HIV exposed infants vaccinated with a MF59/rgp120 vaccine have higher magnitude anti-V1V2 IgG responses than adults immunized with the same vaccine.
    J Virol. 2017 Oct 11. pii: JVI.01070-17. doi: 10.1128/JVI.01070.
    >> Share

  127. CROMER D, Pinkevych M, Rasmussen TA, Lewin SR, et al
    Modelling of anti-latency treatment in HIV; What is the optimal duration of anti-retroviral-free HIV remission?
    J Virol. 2017 Oct 11. pii: JVI.01395-17. doi: 10.1128/JVI.01395.
    >> Share

  128. PAINTER MM, Zaikos TD, Collins KL
    Quiescence promotes latent HIV infection and resistance to reactivation from latency with histone deacetylase inhibitors.
    J Virol. 2017 Oct 11. pii: JVI.01080-17. doi: 10.1128/JVI.01080.
    >> Share

  129. SHEN X, Basu R, Sawant S, Beaumont D, et al
    HIV-1 gp120 Protein and MVAgp140 Boost Immunogens Increase immunogenicity of a DNA/MVA HIV-1 Vaccine.
    J Virol. 2017 Oct 11. pii: JVI.01077-17. doi: 10.1128/JVI.01077.
    >> Share

  130. BRACQ L, Xie M, Lambele M, Vu LT, et al
    T cell-macrophage fusion triggers multinucleated giant cell formation for HIV-1 spreading.
    J Virol. 2017 Oct 4. pii: JVI.01237-17. doi: 10.1128/JVI.01237.
    >> Share

  131. GIFT SK, Leaman DP, Zhang L, Kim AS, et al
    Functional Stability of HIV-1 Envelope Trimer Affects Accessibility to Broadly Neutralizing Antibodies at its Apex.
    J Virol. 2017 Oct 4. pii: JVI.01216-17. doi: 10.1128/JVI.01216.
    >> Share

    September 2017
  132. MARRAS F, Casabianca A, Bozzano F, Ascierto ML, et al
    Control of the HIV-1 DNA Reservoir Is Associated In Vivo and In Vitro with NKp46/NKp30 (CD335 CD337) Inducibility and Interferon Gamma Production by Transcriptionally Unique NK Cells.
    J Virol. 2017 Sep 27. pii: JVI.00647-17. doi: 10.1128/JVI.00647.
    >> Share

  133. FAUTEUX-DANIEL S, Larouche A, Calderon V, Boulais J, et al
    Vertical transmission of hepatitis C virus: variable transmission bottleneck and evidence of mid-gestation in utero infection.
    J Virol. 2017 Sep 20. pii: JVI.01372-17. doi: 10.1128/JVI.01372.
    >> Share

  134. GALVIS AE, Fisher HE, Fan H, Camerini D, et al
    Conformational Changes in the 5' End of the HIV-1 Genome Dependent on the Debranching Enzyme DBR1 During Early Stages of Infection.
    J Virol. 2017 Sep 20. pii: JVI.01377-17. doi: 10.1128/JVI.01377.
    >> Share

  135. VALLE-CASUSO JC, Allouch A, David A, Lenzi GM, et al
    p21 restricts HIV-1 in monocyte-derived dendritic cells through the reduction of dNTP biosynthesis and regulation of SAMHD1 antiviral activity.
    J Virol. 2017 Sep 20. pii: JVI.01324-17. doi: 10.1128/JVI.01324.
    >> Share

  136. CONTRERAS-GALINDO RA, Dube D, Fujinaga K, Kaplan MH, et al
    Susceptibility of Human Endogenous Retrovirus Type-K to Reverse Transcriptase Inhibitors.
    J Virol. 2017 Sep 20. pii: JVI.01309-17. doi: 10.1128/JVI.01309.
    >> Share

  137. RIFE MAGALIS B, Nolan DJ, Autissier P, Burdo TH, et al
    Insights into the impact of CD8+ immune modulation on HIV evolutionary dynamics in distinct anatomical compartments using SIV-infected macaque models of AIDS progression.
    J Virol. 2017 Sep 20. pii: JVI.01162-17. doi: 10.1128/JVI.01162.
    >> Share

  138. BROCCA-COFANO E, Kuhrt D, Siewe B, Xu C, et al
    Pathogenic Correlates of the Simian Immunodeficiency Virus (SIV)-Associated B Cell Dysfunction.
    J Virol. 2017 Sep 20. pii: JVI.01051-17. doi: 10.1128/JVI.01051.
    >> Share

  139. BOMSEL M, Ganor Y
    Calcitonin gene-related peptide induces HIV-1 proteasomal degradation in mucosal Langerhans cells.
    J Virol. 2017 Sep 13. pii: JVI.01205-17. doi: 10.1128/JVI.01205.
    >> Share

  140. TEIGLER JE, Zelinskyy G, Eller MA, Bolton DL, et al
    Differential Inhibitory Receptor Expression on T Cells Delineates Functional Capacities in Chronic Viral Infection.
    J Virol. 2017 Sep 13. pii: JVI.01263-17. doi: 10.1128/JVI.01263.
    >> Share

  141. LITTWITZ-SALOMON E, Schimmer S, Dittmer U
    The dose of retroviral infection determines the induction of anti-viral NK cell responses.
    J Virol. 2017 Sep 13. pii: JVI.01122-17. doi: 10.1128/JVI.01122.
    >> Share

  142. LEITMAN EM, Willberg CB, Tsai MH, Chen H, et al
    J Virol. 2017 Sep 6. pii: JVI.00544-17. doi: 10.1128/JVI.00544.
    >> Share

  143. DE BOER RJ, Perelson AS
    How germinal centers evolve broadly neutralizing antibodies: the breadth of the follicular helper T cell response.
    J Virol. 2017 Sep 6. pii: JVI.00983-17. doi: 10.1128/JVI.00983.
    >> Share

  144. RIZK MG, Basler CF, Guatelli J
    Cooperation of the Ebola proteins VP40 and GP1,2 with BST2 to activate NF-kappabeta independently of virus-like particle trapping.
    J Virol. 2017 Sep 6. pii: JVI.01308-17. doi: 10.1128/JVI.01308.
    >> Share

  145. SULLIVAN JT, Sulli C, Nilo A, Yasmeen A, et al
    High-throughput Protein Engineering Improves the Antigenicity and Stability of Soluble HIV-1 Envelope Glycoprotein SOSIP Trimers.
    J Virol. 2017 Sep 6. pii: JVI.00862-17. doi: 10.1128/JVI.00862.
    >> Share

    August 2017
  146. ANSTETT K, Brenner B, Mesplede T, Wainberg MA, et al
    HIV-1 resistance to dolutegravir is affected by cellular histone acetyltransferase activity.
    J Virol. 2017 Aug 23. pii: JVI.00912-17. doi: 10.1128/JVI.00912.
    >> Share

  147. WANG Y, O'Dell S, Turner HL, Chiang CI, et al
    HIV-1 Cross-reactive Primary Virus Neutralizing Antibody Response Elicited by Immunization in Non-human Primate.
    J Virol. 2017 Aug 23. pii: JVI.00910-17. doi: 10.1128/JVI.00910.
    >> Share

  148. DUCHON AA, St-Gelais C, Titkemeier N, Hatterschide J, et al
    HIV-1 exploits dynamic multi-aminoacyl-tRNA synthetase complex to enhance viral replication.
    J Virol. 2017 Aug 16. pii: JVI.01240-17. doi: 10.1128/JVI.01240.
    >> Share

  149. CHAUVEAU L, Donahue DA, Monel B, Porrot F, et al
    HIV fusion in Dendritic cells mainly occurs at the surface and is limited by low CD4 levels.
    J Virol. 2017 Aug 16. pii: JVI.01248-17. doi: 10.1128/JVI.01248.
    >> Share

  150. O'CARROLL IP, Thappeta Y, Fan L, Ramirez-Valdez EA, et al
    Contributions of individual domains to function of the HIV-1 Rev response element.
    J Virol. 2017 Aug 16. pii: JVI.00746-17. doi: 10.1128/JVI.00746.
    >> Share

  151. PLOTNIK D, Guo W, Cleveland B, von Haller P, et al
    Extracellular Matrix Proteins Mediate HIV-1 gp120 Interactions with alpha4beta7.
    J Virol. 2017 Aug 16. pii: JVI.01005-17. doi: 10.1128/JVI.01005.
    >> Share

  152. CHAILLON A, Nakazawa M, Wertheim JO, Little SJ, et al
    No Substantial Evidence for Sexual Transmission of Minority HIV Drug Resistance Mutations in Men Who Have Sex with Men.
    J Virol. 2017 Aug 9. pii: JVI.00769-17. doi: 10.1128/JVI.00769.
    >> Share

  153. AKIYAMA H, Ramirez NP, Gibson G, Kline C, et al
    Interferon-Inducible CD169/Siglec1 Attenuates Anti-HIV-1 Effects of IFN-alpha.
    J Virol. 2017 Aug 9. pii: JVI.00972-17. doi: 10.1128/JVI.00972.
    >> Share

  154. HAN Q, Williams WB, Saunders KO, Seaton KE, et al
    HIV DNA-Adenovirus Multiclade Envelope Vaccine Induces Gp41 Antibody Immunodominance in Rhesus Macaques.
    J Virol. 2017 Aug 9. pii: JVI.00923-17. doi: 10.1128/JVI.00923.
    >> Share

  155. PITOISET F, Vazquez T, Levacher B, Nehar-Belaid D, et al
    Retrovirus-based Virus-Like Particle Immunogenicity and its Modulation by Toll-Like Receptor Activation.
    J Virol. 2017 Aug 9. pii: JVI.01230-17. doi: 10.1128/JVI.01230.
    >> Share

  156. BARDHI A, Wu Y, Chen W, Zhu Z, et al
    Potent In Vivo NK Cell-mediated Elimination of HIV-1-Infected Cells Mobilized by a gp120-bispecific and Hexavalent Broadly Neutralizing Fusion Protein.
    J Virol. 2017 Aug 9. pii: JVI.00937-17. doi: 10.1128/JVI.00937.
    >> Share

  157. JULG B, Sok D, Schmidt SD, Abbink P, et al
    Protective Efficacy of Broadly Neutralizing Antibodies with Incomplete Neutralization Activity Against SHIV in Rhesus Monkeys.
    J Virol. 2017 Aug 2. pii: JVI.01187-17. doi: 10.1128/JVI.01187.
    >> Share

  158. NASR N, Alshehri AA, Wright TK, Shahid M, et al
    Mechanism of Interferon Stimulated Gene Induction in HIV-1 Infected Macrophages.
    J Virol. 2017 Aug 2. pii: JVI.00744-17. doi: 10.1128/JVI.00744.
    >> Share

  159. GONZALEZ-PEREZ MP, Peters PJ, O'Connell O, Silva N, et al
    Identification of emerging mac-tropic HIV-1 R5 variants in brain tissue of patients without severe neurological complications.
    J Virol. 2017 Aug 2. pii: JVI.00755-17. doi: 10.1128/JVI.00755.
    >> Share

    July 2017
  160. HRABER P, Rademeyer C, Williamson C, Seaman MS, et al
    Panels of HIV-1 Subtype C Env Reference Strains for Standardized Neutralization Assessments.
    J Virol. 2017 Jul 26. pii: JVI.00991-17. doi: 10.1128/JVI.00991.
    >> Share

  161. SCHALLER T, Bulli L, Pollpeter D, Betancor G, et al
    Effects of the inner nuclear membrane proteins SUN1/UNC-84A and SUN2/UNC-84B on the early steps of HIV-1 infection.
    J Virol. 2017 Jul 26. pii: JVI.00463-17. doi: 10.1128/JVI.00463.
    >> Share

  162. TERMINI JM, Church ES, Silver ZA, Haslam SM, et al
    HIV and SIV Maintain High Levels of Infectivity in the Complete Absence of Mucin Type O-Glycosylation.
    J Virol. 2017 Jul 26. pii: JVI.01228-17. doi: 10.1128/JVI.01228.
    >> Share

  163. YU FH, Huang KJ, Wang CT
    Correction for Yu et al., "C-Terminal HIV-1 Transframe p6* Tetrapeptide Blocks Enhanced Gag Cleavage Incurred by Leucine Zipper Replacement of a Deleted p6* Domain".
    J Virol. 2017;91.
    >> Share

  164. WANG K, Tomaras GD, Jegaskanda S, Moody MA, et al
    Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate ADCC, and Protect Mice from Ocular Challenge with HSV-1
    J Virol. 2017 Jul 12. pii: JVI.00411-17. doi: 10.1128/JVI.00411.
    >> Share

  165. BOGERS WMJM, Barnett SW, Oostermeijer H, Nieuwenhuis IG, et al
    Increased, durable B-cell and ADCC Responses Associated with T-helper Responses to HIV-1 Envelope in Macaques Vaccinated with gp140 Occluded at the CD4 Receptor Binding Site.
    J Virol. 2017 Jul 12. pii: JVI.00811-17. doi: 10.1128/JVI.00811.
    >> Share

    Protection against HIV Acquisition in the RV144 Trial.
    J Virol. 2017 Jul 12. pii: JVI.00905-17. doi: 10.1128/JVI.00905.
    >> Share

  167. BAUER A, Podola L, Mann P, Missanga M, et al
    Preferential Targeting of Conserved Gag Regions after Vaccination with a Heterologous DNA prime - Modified Vaccinia Ankara (MVA) boost HIV-1 vaccine regimen.
    J Virol. 2017 Jul 12. pii: JVI.00730-17. doi: 10.1128/JVI.00730.
    >> Share

  168. MADHAVI V, Wines BD, Amin J, Emery S, et al
    HIV-1 Env- and Vpu-specific antibody-dependent cellular cytotoxicity responses associated with elite control of HIV.
    J Virol. 2017 Jul 12. pii: JVI.00700-17. doi: 10.1128/JVI.00700.
    >> Share

  169. ANTHONY C, York T, Bekker V, Matten D, et al
    Co-operation between strain-specific and broadly neutralizing responses limited viral escape, and prolonged exposure of the broadly neutralizing epitope.
    J Virol. 2017 Jul 5. pii: JVI.00828-17. doi: 10.1128/JVI.00828.
    >> Share

  170. KE R, Cong ME, Li D, Garcia-Lerma G, et al
    On the death rate of abortively infected cells: estimation from simian/human immunodeficiency virus infection.
    J Virol. 2017 Jul 5. pii: JVI.00352-17. doi: 10.1128/JVI.00352.
    >> Share

  171. FELLINGER CH, Gardner MR, Bailey CC, Farzan M, et al
    SIVmac239, but not SIVmac316, binds and utilizes human CD4 more efficiently than rhesus CD4.
    J Virol. 2017 Jul 5. pii: JVI.00847-17. doi: 10.1128/JVI.00847.
    >> Share

  172. FUJINO M, Sato H, Okamura T, Uda A, et al
    Simian Immunodeficiency Virus Targeting of CXCR3+ CD4+ T Cells in Secondary Lymphoid Organs Is Associated with Robust CXCL10 Expression in Monocyte/Macrophage Subsets.
    J Virol. 2017;91.
    >> Share

    June 2017
  173. DING X, Zhang X, Chong H, Zhu Y, et al
    Enfuvirtide (T20)-based Lipopeptide Is a Potent HIV-1 Cell Fusion Inhibitor: Implication for Viral Entry and Inhibition.
    J Virol. 2017 Jun 28. pii: JVI.00831-17. doi: 10.1128/JVI.00831.
    >> Share

  174. ARIF MS, Hunter J, Leda AR, Zukurov JPL, et al
    The Pace of Co-receptor Tropism Switch in HIV-1 Infected Individuals after Recent Infection.
    J Virol. 2017 Jun 28. pii: JVI.00793-17. doi: 10.1128/JVI.00793.
    >> Share

  175. NAIDOO VL, Mann JK, Noble C, Adland E, et al
    Mother-to-Child HIV Transmission Bottleneck Selects for Consensus Virus with Lower Gag-Protease-driven Replication Capacity.
    J Virol. 2017 Jun 21. pii: JVI.00518-17. doi: 10.1128/JVI.00518.
    >> Share

  176. SHI Y, Kawana-Tachikawa A, Gao F, Qi J, et al
    Conserved Vdelta1 binding geometry in a setting of locus-disparate pHLA recognition by delta/alphabetaTCRs: insight into recognition of HIV peptides by TCR.
    J Virol. 2017 Jun 14. pii: JVI.00725-17. doi: 10.1128/JVI.00725.
    >> Share

  177. MADISON MK, Lawson DQ, Elliott J, Ozanturk AN, et al
    Allosteric HIV-1 Integrase Inhibitors Lead to Premature Degradation of the Viral RNA Genome and Integrase in Target Cells.
    J Virol. 2017 Jun 14. pii: JVI.00821-17. doi: 10.1128/JVI.00821.
    >> Share

  178. POWELL RLR, Totrov M, Itri V, Liu X, et al
    Plasticity and Epitope Exposure of the HIV-1 Envelope Trimer.
    J Virol. 2017 Jun 14. pii: JVI.00410-17. doi: 10.1128/JVI.00410.
    >> Share

  179. WAGNER GA, Landais E, Caballero G, Phung P, et al
    Intrasubtype B HIV-1 Superinfection Correlates with Delayed Neutralizing Antibody Response.
    J Virol. 2017 Jun 14. pii: JVI.00475-17. doi: 10.1128/JVI.00475.
    >> Share

  180. MILLER SM, Miles B, Guo K, Folkvord J, et al
    Follicular regulatory T cells are highly permissive to R5-tropic HIV-1.
    J Virol. 2017 Jun 14. pii: JVI.00430-17. doi: 10.1128/JVI.00430.
    >> Share

  181. ALSAHAFI N, Richard J, Prevost J, Coutu M, et al
    Impaired downregulation of NKG2D ligands by Nef protein from elite controllers sensitizes HIV-1-infected cells to ADCC.
    J Virol. 2017 Jun 14. pii: JVI.00109-17. doi: 10.1128/JVI.00109.
    >> Share

  182. BALE S, Goebrecht G, Stano A, Wilson R, et al
    Covalent linkage of HIV-1 trimers to synthetic liposomes elicits improved B cell and antibody responses.
    J Virol. 2017 Jun 7. pii: JVI.00443-17. doi: 10.1128/JVI.00443.
    >> Share

  183. BALAMURUGAN A, Claiborne D, Ng HL, Yang OO, et al
    HIV-1 Epitope Variability Is Associated With T Cell Receptor Repertoire Instability and Breadth.
    J Virol. 2017 Jun 7. pii: JVI.00771-17. doi: 10.1128/JVI.00771.
    >> Share

  184. RUIZ-RIOL M, Berdnik D, Llano A, Mothe B, et al
    Identification of IL-27/IL-27RA as a critical immune axis for in vivo HIV control.
    J Virol. 2017 Jun 7. pii: JVI.00441-17. doi: 10.1128/JVI.00441.
    >> Share

  185. MAZZUCA P, Marsico S, Schulze K, Mitola S, et al
    Role of autophagy in the HIV-1 matrix protein p17-driven lymphangiogenesis.
    J Virol. 2017 Jun 7. pii: JVI.00801-17. doi: 10.1128/JVI.00801.
    >> Share

  186. MUJIB S, Liu J, Rahman AKMN, Schwartz JA, et al
    Comprehensive cross-clade characterization of antibody-mediated recognition, complement-mediated lysis and cell-mediated cytotoxicity of HIV-1 envelope specific antibodies towards the eradication of the HIV-1 reservoir.
    J Virol. 2017 Jun 7. pii: JVI.00634-17. doi: 10.1128/JVI.00634.
    >> Share

    May 2017
  187. SUGIMOTO C, Merino KM, Hasegawa A, Wang X, et al
    A Critical Role for Monocytes/Macrophages in the Rapid Progression to AIDS in Pediatric SIV-Infected Rhesus Macaques.
    J Virol. 2017 May 31. pii: JVI.00379-17. doi: 10.1128/JVI.00379.
    >> Share

  188. BOLDUC JF, Hany L, Barat C, Ouellet M, et al
    Epigenetic metabolite acetate inhibits class I/II histone deacetylases, promotes histone acetylation and increases HIV-1 integration in CD4+ T cells.
    J Virol. 2017 May 24. pii: JVI.01943-16. doi: 10.1128/JVI.01943.
    >> Share

  189. DILLEY KA, Nikolaitchik OA, Galli A, Burdick RC, et al
    Interactions Between HIV-1 Gag and Viral RNA Genome Enhance Virion Assembly.
    J Virol. 2017 May 24. pii: JVI.02319-16. doi: 10.1128/JVI.02319.
    >> Share

  190. RINGE RP, Ozorowski G, Rantalainen K, Struwe WB, et al
    Reducing V3 antigenicity and immunogenicity on soluble, native-like HIV-1 Env SOSIP trimers.
    J Virol. 2017 May 24. pii: JVI.00677-17. doi: 10.1128/JVI.00677.
    >> Share

  191. LEE WS, Kristensen AB, Rasmussen TA, Tolstrup M, et al
    Anti-HIV-1 ADCC antibodies following latency reversal and treatment interruption.
    J Virol. 2017 May 24. pii: JVI.00603-17. doi: 10.1128/JVI.00603.
    >> Share

  192. JULG B, Pegu A, Abbink P, Liu J, et al
    Virological control by the CD4-binding site antibody N6 in SHIV-infected rhesus monkeys.
    J Virol. 2017 May 24. pii: JVI.00498-17. doi: 10.1128/JVI.00498.
    >> Share

  193. HU G, Liu J, Roux KH, Taylor KA, et al
    Structure of Simian Immunodeficiency Virus Envelope Spikes bound with CD4 and Monoclonal Antibody 36D5.
    J Virol. 2017 May 24. pii: JVI.00134-17. doi: 10.1128/JVI.00134.
    >> Share

  194. ZHAO M, Zheng ZZ, Chen M, Modjarrad K, et al
    Discovery of a Prefusion RSV F-Specific Monoclonal Antibody that Provides Greater in vivo Protection than the Murine Precursor of Palivizumab.
    J Virol. 2017 May 24. pii: JVI.00176-17. doi: 10.1128/JVI.00176.
    >> Share

  195. DECALF J, Desdouits M, Rodrigues V, Gobert FX, et al
    Sensing of HIV-1 entry triggers a type I interferon response in human primary macrophages.
    J Virol. 2017 May 10. pii: JVI.00147-17. doi: 10.1128/JVI.00147.
    >> Share

  196. JOHNSON J, Zhai Y, Salimi H, Espy N, et al
    Induction of a Tier-1-like Phenotype in Diverse Tier-2 Isolates by Agents that Guide HIV-1 Env to Perturbation-sensitive, Non-native States.
    J Virol. 2017 May 10. pii: JVI.00174-17. doi: 10.1128/JVI.00174.
    >> Share

  197. SHEN X, Bogers WM, Yates NL, Ferrari G, et al
    Crosslinking of a CD4 Mimetic Miniprotein with HIV-1 Env gp140 Alters Kinetics and Specificities of Antibody Responses against HIV-1 Env in Macaques.
    J Virol. 2017 May 10. pii: JVI.00401-17. doi: 10.1128/JVI.00401.
    >> Share

  198. BURANAPRADITKUN S, Pissani F, Teigler JE, Schultz BT, et al
    Preservation of peripheral T follicular helper cell function in HIV controllers.
    J Virol. 2017 May 3. pii: JVI.00497-17. doi: 10.1128/JVI.00497.
    >> Share

    April 2017
  199. MARTIN JL, Mendonca L, Angert I, Mueller JD, et al
    Disparate contributions of human retrovirus capsid subdomains to Gag-Gag oligomerization, virus morphology and particle biogenesis.
    J Virol. 2017 Apr 26. pii: JVI.00298-17. doi: 10.1128/JVI.00298.
    >> Share

  200. STANO A, Leaman DP, Kim AS, Zhang L, et al
    Dense array of spikes on HIV-1 virion particles.
    J Virol. 2017 Apr 26. pii: JVI.00415-17. doi: 10.1128/JVI.00415.
    >> Share

  201. BRILLEN AL, Walotka L, Hillebrand F, Muller L, et al
    Analysis of competing HIV-1 splice donor sites uncovers a tight cluster of splicing regulatory elements within exon 2/2b.
    J Virol. 2017 Apr 26. pii: JVI.00389-17. doi: 10.1128/JVI.00389.
    >> Share

  202. MILLER CM, Akiyama H, Agosto LM, Emery A, et al
    Virion associated Vpr alleviates a post-integration block to HIV-1 infection of dendritic cells.
    J Virol. 2017 Apr 19. pii: JVI.00051-17. doi: 10.1128/JVI.00051.
    >> Share

  203. KIGUOYA MW, Mann JK, Chopera D, Gounder K, et al
    Subtype-Specific Differences in Gag-Protease-Driven Replication Capacity are Consistent with Inter-Subtype Differences in HIV-1 Disease Progression.
    J Virol. 2017 Apr 19. pii: JVI.00253-17. doi: 10.1128/JVI.00253.
    >> Share

  204. DI PILATO M, Mejias-Perez E, Sorzano COS, Esteban M, et al
    Distinct roles of vaccinia virus NF-kB inhibitor proteins A52, B15 and K7 in the immune response.
    J Virol. 2017 Apr 19. pii: JVI.00575-17. doi: 10.1128/JVI.00575.
    >> Share

  205. REEVES DB, Peterson CW, Kiem HP, Schiffer JT, et al
    Autologous stem-cell transplantation disrupts adaptive immune responses during rebound SHIV viremia.
    J Virol. 2017 Apr 12. pii: JVI.00095-17. doi: 10.1128/JVI.00095.
    >> Share

  206. RANKOVIC S, Varadarajan J, Ramalho R, Aiken C, et al
    Reverse transcription mechanically initiates HIV-1 capsid disassembly.
    J Virol. 2017 Apr 5. pii: JVI.00289-17. doi: 10.1128/JVI.00289.
    >> Share

  207. RINGE RP, Ozorowski G, Yasmeen A, Cupo A, et al
    Improving the expression and purification of soluble, recombinant native-like HIV-1 envelope glycoprotein trimers by targeted sequence changes.
    J Virol. 2017 Apr 5. pii: JVI.00264-17. doi: 10.1128/JVI.00264.
    >> Share

  208. YI F, Guo J, Dabbagh D, Spear M, et al
    Discovery of Novel Small Molecule Inhibitors of LIM Domain Kinase for Inhibiting HIV-1.
    J Virol. 2017 Apr 5. pii: JVI.02418-16. doi: 10.1128/JVI.02418.
    >> Share

  209. BAIG TT, Feng Y, Chelico L
    Correction for Baig et al., Determinants of Efficient Degradation of APOBEC3 Restriction Factors by HIV-1 Vif.
    J Virol. 2017;91.
    >> Share

    March 2017
  210. CHONG H, Xue J, Xiong S, Cong Z, et al
    A Lipopeptide HIV-1/2 Fusion Inhibitor with Highly Potent in vitro, ex vivo and in vivo Antiviral Activity.
    J Virol. 2017 Mar 29. pii: JVI.00288-17. doi: 10.1128/JVI.00288.
    >> Share

  211. PETERLIN BM, Liu P, Wang X, Cary D, et al
    Hili inhibits HIV replication in activated T cells.
    J Virol. 2017 Mar 22. pii: JVI.00237-17. doi: 10.1128/JVI.00237.
    >> Share

  212. RICHARD J, Prevost J, von Bredow B, Ding S, et al
    BST-2 Expression Modulates Small CD4 Mimetic Sensitization of HIV-1-infected cells to ADCC.
    J Virol. 2017 Mar 22. pii: JVI.00219-17. doi: 10.1128/JVI.00219.
    >> Share

  213. YOSHIKAWA R, Takeuchi JS, Yamada E, Nakano Y, et al
    Feline immunodeficiency virus evolutionarily acquires two proteins, Vif and protease, capable of antagonizing feline APOBEC3.
    J Virol. 2017 Mar 22. pii: JVI.00250-17. doi: 10.1128/JVI.00250.
    >> Share

  214. CUMMINS NW, Sainski-Nguyen AM, Natesampillai S, Aboulnasr F, et al
    Maintenance of the HIV reservoir is antagonized by selective BCL2 inhibition.
    J Virol. 2017 Mar 22. pii: JVI.00012-17. doi: 10.1128/JVI.00012.
    >> Share

  215. GAO J, Hay TJ, Banfield BW
    The Product of the Herpes Simplex Virus Type 2 UL16 Gene is Critical for the Egress of Capsids from the Nuclei of Infected Cells.
    J Virol. 2017 Mar 8. pii: JVI.00350-17. doi: 10.1128/JVI.00350.
    >> Share

  216. CHUANG GY, Geng H, Pancera M, Xu K, et al
    Structure-Based Design of a Soluble Prefusion-Closed HIV-1-Env Trimer with Reduced CD4 Affinity and Improved Immunogenicity.
    J Virol. 2017 Mar 8. pii: JVI.02268-16. doi: 10.1128/JVI.02268.
    >> Share

  217. ZHANG X, Zhou T, Yang J, Lin Y, et al
    Identification of SERINC5-001 as the Predominant Spliced Isoform for HIV-1 Restriction.
    J Virol. 2017 Mar 8. pii: JVI.00137-17. doi: 10.1128/JVI.00137.
    >> Share

  218. MARNO KM, O'Sullivan E, Jones CE, Diaz-Delfin J, et al
    RNA-associated Early-stage Anti-viral Factor (REAF) is a major component of LV2 restriction.
    J Virol. 2017 Mar 8. pii: JVI.01228-16. doi: 10.1128/JVI.01228.
    >> Share

  219. HUANG J, Zhu L, Qiu C, Xu X, et al
    MiR-126-5p enhances the inflammatory responses of monocytes to LPS stimulation by suppressing CYLD in chronic HIV-1 infection.
    J Virol. 2017 Mar 1. pii: JVI.02048-16. doi: 10.1128/JVI.02048.
    >> Share

  220. LIU Y, Pan J, Cai Y, Grigorieff N, et al
    Conformational states of a soluble, uncleaved HIV-1 envelope trimer.
    J Virol. 2017 Mar 1. pii: JVI.00175-17. doi: 10.1128/JVI.00175.
    >> Share

  221. OPAZO T, Garces A, Tapia D, Barraza F, et al
    Functional evidence of the involvement of the dynein light chain DYNLRB2 in murine leukemia virus infection.
    J Virol. 2017 Mar 1. pii: JVI.00129-17. doi: 10.1128/JVI.00129.
    >> Share

  222. SMITH SA, Derdeyn CA
    New connections: Cell to cell HIV-1 transmission, resistance to broadly neutralizing antibodies, and an envelope sorting motif.
    J Virol. 2017 Mar 1. pii: JVI.00149-17. doi: 10.1128/JVI.00149.
    >> Share

  223. STULTZ RD, Cenker JJ, McDonald D
    Imaging HIV-1 Genomic DNA from Entry through Productive Infection.
    J Virol. 2017 Mar 1. pii: JVI.00034-17. doi: 10.1128/JVI.00034.
    >> Share

  224. KENNEDY EM, Courtney DG, Tsai K, Cullen BR, et al
    Viral Epitranscriptomics.
    J Virol. 2017 Mar 1. pii: JVI.02263-16. doi: 10.1128/JVI.02263.
    >> Share

  225. YU FH, Huang KJ, Wang CT
    C-terminal HIV-1 transframe p6* tetra-peptide blocks enhanced Gag cleavage incurred by leucine zipper replacement of a deleted p6* domain.
    J Virol. 2017 Mar 1. pii: JVI.00103-17. doi: 10.1128/JVI.00103.
    >> Share

    February 2017
  226. WANG W, Zhou J, Halambage UD, Jurado KA, et al
    Inhibition of HIV-1 Maturation via Small Molecule Targeting of the Amino-Terminal Domain in the Viral Capsid Protein.
    J Virol. 2017 Feb 15. pii: JVI.02155-16. doi: 10.1128/JVI.02155.
    >> Share

  227. ZHENG X, Wang X, Tu F, Wang Q, et al
    TRIM25 Is Required for the Antiviral Activity of Zinc-finger Antiviral Protein (ZAP).
    J Virol. 2017 Feb 15. pii: JVI.00088-17. doi: 10.1128/JVI.00088.
    >> Share

  228. WANG H, Guo H, Su J, Rui Y, et al
    Inhibition of Vpx-mediated SAMHD1 and Vpr-mediated HLTF degradation by selective disruption of viral CRL4 (DCAF1) E3 ubiquitin ligase assembly.
    J Virol. 2017 Feb 15. pii: JVI.00225-17. doi: 10.1128/JVI.00225.
    >> Share

  229. MARTINEZ DR, Vandergrift N, Douglas AO, McGuire E, et al
    Maternal binding and neutralizing IgG responses targeting the C terminal region of the V3 loop are predictive of reduced peripartum HIV-1 transmission risk.
    J Virol. 2017 Feb 15. pii: JVI.02422-16. doi: 10.1128/JVI.02422.
    >> Share

  230. PETRAVIC J, Rasmussen TA, Lewin SR, Kent SJ, et al
    Relationship between measures of HIV reactivation and the decline of latent reservoir under latency-reversing agents.
    J Virol. 2017 Feb 15. pii: JVI.02092-16. doi: 10.1128/JVI.02092.
    >> Share

  231. GO EP, Ding H, Zhang S, Ringe RP, et al
    A glycosylation benchmark profile for HIV-1 envelope glycoprotein production based on eleven Env trimers.
    J Virol. 2017 Feb 15. pii: JVI.02428-16. doi: 10.1128/JVI.02428.
    >> Share

  232. QUAN Y, Xu H, Han Y, Mesplede T, et al
    JAK-STAT Signaling Pathways and Inhibitors Affect Reversion of Envelope Mutated HIV-1.
    J Virol. 2017 Feb 15. pii: JVI.00075-17. doi: 10.1128/JVI.00075.
    >> Share

  233. ZURAWSKI G, Shen X, Zurawski S, Tomaras GD, et al
    Superiority in Rhesus Macaques of Targeting HIV-1 Env Gp140 to CD40 Versus LOX-1 in Combination with Replication Competent NYVAC-KC for Induction of Env-Specific Antibody and T Cell Responses.
    J Virol. 2017 Feb 15. pii: JVI.01596-16. doi: 10.1128/JVI.01596.
    >> Share

  234. GARCIA-ARRIAZA J, Perdiguero B, Heeney JL, Seaman MS, et al
    HIV/AIDS vaccine candidates based on replication-competent recombinant poxvirus NYVAC-C-KC expressing trimeric gp140 and Gag-derived VLPs or lacking the viral molecule B19 that inhibits type I interferon activate relevant HIV-1-specific B and T cell i
    J Virol. 2017 Feb 8. pii: JVI.02182-16. doi: 10.1128/JVI.02182.
    >> Share

  235. TSAI A, Irrinki A, Kaur J, Cihlar T, et al
    Toll-Like Receptor 7 Agonist GS-9620 Induces HIV Expression and HIV-Specific Immunity in Cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy.
    J Virol. 2017 Feb 8. pii: JVI.02166-16. doi: 10.1128/JVI.02166.
    >> Share

  236. YUE FY, Cohen JC, Ho M, Rahman AK, et al
    HIV-specific granzyme B, but not interferon-gamma secreting T Cells are associated with reduced viral reservoirs in early HIV infection.
    J Virol. 2017 Feb 8. pii: JVI.02233-16. doi: 10.1128/JVI.02233.
    >> Share

  237. LUND JM, Broliden K, Pyra MN, Thomas KK, et al
    Correction for Lund et al., HIV-1-Neutralizing IgA Detected in Genital Secretions of Highly HIV-1-Exposed Seronegative Women on Oral Preexposure Prophylaxis.
    J Virol. 2017;91.
    >> Share

  238. NASAR F, Matassov D, Seymour RL, Latham T, et al
    Recombinant Isfahan virus and vesicular stomatitis virus vaccine vectors provide durable, multivalent, single dose protection against lethal alphavirus challenge.
    J Virol. 2017 Feb 1. pii: JVI.01729-16. doi: 10.1128/JVI.01729.
    >> Share

  239. LI H, Zony C, Chen P, Chen BK, et al
    Reduced potency and incomplete neutralization of broadly neutralizing antibodies against cell-to-cell transmission of HIV-1 with transmitted founder Envs.
    J Virol. 2017 Feb 1. pii: JVI.02425-16. doi: 10.1128/JVI.02425.
    >> Share

  240. SUGDEN SM, Pham TN, Cohen EA
    HIV-1 Vpu downmodulates ICAM-1 expression resulting in decreased killing of infected CD4+ T cells by NK cells.
    J Virol. 2017 Feb 1. pii: JVI.02442-16. doi: 10.1128/JVI.02442.
    >> Share

  241. SELHORST P, Combrinck C, Ndabambi N, Ismail SD, et al
    J Virol. 2017 Feb 1. pii: JVI.01806-16. doi: 10.1128/JVI.01806.
    >> Share

  242. CALONGE E, Bermejo M, Diez-Fuertes F, Mangeot I, et al
    Different Expression of Interferon Stimulated Genes in Response to HIV-1 Infection in Dendritic Cells According to Their Maturation State.
    J Virol. 2017 Feb 1. pii: JVI.01379-16. doi: 10.1128/JVI.01379.
    >> Share

    January 2017
  243. COLOMER-LLUCH M, Serra-Moreno R
    BCA2/RABRING7 Interferes with HIV-1 Proviral Transcription by Enhancing the SUMOylation of IkappaBalpha.
    J Virol. 2017 Jan 25. pii: JVI.02098-16. doi: 10.1128/JVI.02098.
    >> Share

  244. BRUEL T, Guivel-Benhassine F, Lorin V, Lortat-Jacob H, et al
    Lack of ADCC breadth of human non-neutralizing anti-HIV-1 antibodies.
    J Virol. 2017 Jan 25. pii: JVI.02440-16. doi: 10.1128/JVI.02440.
    >> Share

  245. ZHENG W, Ling L, Li Z, Wang H, et al
    Conserved interaction of lentiviral Vif molecules with HIV-1 Gag and differential effects of species-specific Vif on virus production.
    J Virol. 2017 Jan 25. pii: JVI.00064-17. doi: 10.1128/JVI.00064.
    >> Share

  246. WINANS S, Larue RC, Abraham CM, Shkriabai N, et al
    The FACT complex promotes avian leukosis virus DNA integration.
    J Virol. 2017 Jan 25. pii: JVI.00082-17. doi: 10.1128/JVI.00082.
    >> Share

  247. MUSICH T, Li L, Liu L, Zolla-Pazner S, et al
    Monoclonal Antibodies to V2, V3, the CD4-binding site and gp41 HIV-1 Mediate Phagocytosis in a Dose-dependent Manner.
    J Virol. 2017 Jan 25. pii: JVI.02325-16. doi: 10.1128/JVI.02325.
    >> Share

  248. PREVOST J, Zoubchenok D, Richard J, Veillette M, et al
    Influence of the Envelope Gp120 Phe 43 Cavity on HIV-1 Sensitivity to ADCC Responses.
    J Virol. 2017 Jan 18. pii: JVI.02452-16. doi: 10.1128/JVI.02452.
    >> Share

  249. WANG Y, Pan Q, Ding S, Wang Z, et al
    The V3-loop of HIV-1 Env determines viral susceptibility to IFITM3 impairment of viral infectivity.
    J Virol. 2017 Jan 18. pii: JVI.02441-16. doi: 10.1128/JVI.02441.
    >> Share

  250. RAHMBERG AR, Rajakumar PA, Billingsley JM, Johnson RP, et al
    Dynamic modulation of expression of lentiviral restriction factors in primary CD4+ T cells following SIV infection.
    J Virol. 2017 Jan 18. pii: JVI.02189-16. doi: 10.1128/JVI.02189.
    >> Share

  251. RIHN SJ, Foster TL, Busnadiego I, Aziz MA, et al
    The Envelope Gene of Transmitted HIV-1 Resists a Late IFNgamma-Induced Block.
    J Virol. 2017 Jan 18. pii: JVI.02254-16. doi: 10.1128/JVI.02254.
    >> Share

  252. LAHER F, Ranasinghe S, Porichis F, Mewalal N, et al
    HIV controllers exhibit enhanced frequencies of MHC class II tetramer+ Gag-specific CD4+ T cells in chronic clade C HIV-1 infection.
    J Virol. 2017 Jan 11. pii: JVI.02477-16. doi: 10.1128/JVI.02477.
    >> Share

  253. EMERY A, Zhou S, Pollom E, Swanstrom R, et al
    Characterizing HIV-1 Splicing Using Next Generation Sequencing.
    J Virol. 2017 Jan 11. pii: JVI.02515-16. doi: 10.1128/JVI.02515.
    >> Share

  254. FLERIN NC, Chen H, Glover TD, Lamothe PA, et al
    TCR Clonotype-specific Differences in Inhibitory Activity of HIV-1 Cytotoxic T Cell Clones is Not Mediated by TCR Alone.
    J Virol. 2017 Jan 11. pii: JVI.02412-16. doi: 10.1128/JVI.02412.
    >> Share

  255. RODGERS MA, Wilkerson E, Vallari A, McArthur C, et al
    Sensitive next generation sequencing method reveals deep genetic diversity of HIV-1 in the Democratic Republic of the Congo.
    J Virol. 2017 Jan 11. pii: JVI.01841-16. doi: 10.1128/JVI.01841.
    >> Share

  256. PEREIRA BITTENCOURT PASSAES C, Bruel T, Decalf J, David A, et al
    Ultrasensitive HIV-1 p24 detects single infected cells and differences in reservoir induction by latency-reversal agents.
    J Virol. 2017 Jan 11. pii: JVI.02296-16. doi: 10.1128/JVI.02296.
    >> Share

  257. MACK K, Starz K, Sauter D, Langer S, et al
    Efficient Vpu-mediated tetherin antagonism by an HIV-1 group O strain.
    J Virol. 2017 Jan 11. pii: JVI.02177-16. doi: 10.1128/JVI.02177.
    >> Share

  258. HO CK, Raghwani J, Koekkoek S, Liang RH, et al
    Characterization of HCV envelope diversification from acute to chronic infection using SMRT sequencing within a sexually-transmitted hepatitis C virus cluster.
    J Virol. 2017 Jan 11. pii: JVI.02262-16. doi: 10.1128/JVI.02262.
    >> Share

  259. SCHMIDT F, Liegeois F, Greenwood EJ, LeBreton M, et al
    Phyloepidemiological analysis reveals that viral divergence led to the paucity of SIVmus/gsn/mon infections in wild populations.
    J Virol. 2017 Jan 11. pii: JVI.01884-16. doi: 10.1128/JVI.01884.
    >> Share

  260. DONAHUE DA, Porrot F, Couespel N, Schwartz O, et al
    SUN2 silencing impairs CD4 T cell proliferation and alters sensitivity to HIV-1 infection independently of Cyclophilin A.
    J Virol. 2017 Jan 11. pii: JVI.02303-16. doi: 10.1128/JVI.02303.
    >> Share

  261. JACOBS ES, Keating SM, Abdel-Mohsen M, Gibb SL, et al
    Cytokines Elevated in HIV Elite Controllers Reduce HIV Replication in vitro and Modulate HIV Restriction Factor Expression.
    J Virol. 2017 Jan 4. pii: JVI.02051-16. doi: 10.1128/JVI.02051.
    >> Share

  262. BECKER JT, Sherer NM
    Subcellular localization of HIV-1 gag-pol mRNAs regulates sites of virion assembly.
    J Virol. 2017 Jan 4. pii: JVI.02315-16. doi: 10.1128/JVI.02315.
    >> Share

    December 2016
  263. OOMS M, Letko M, Simon V
    The structural interface between HIV-1 Vif and human APOBEC3H.
    J Virol. 2016 Dec 28. pii: JVI.02289-16. doi: 10.1128/JVI.02289.
    >> Share

  264. PACHECO B, Alsahafi N, Debbeche O, Prevost J, et al
    Residues in the gp41 Ectodomain Regulate HIV-1 Envelope Glycoprotein Conformational Transitions Induced by gp120-directed Inhibitors.
    J Virol. 2016 Dec 21. pii: JVI.02219-16. doi: 10.1128/JVI.02219.
    >> Share

  265. LEE J, Malmberg JL, Wood BA, Hladky S, et al
    Feline immunodeficiency virus cross-species transmission: Implications for emergence of new lentiviral infections.
    J Virol. 2016 Dec 21. pii: JVI.02134-16. doi: 10.1128/JVI.02134.
    >> Share

  266. BOLDUC JF, Ouellet M, Hany L, Tremblay MJ, et al
    TLR2 ligation enhances HIV-1 replication in activated CCR6+CD4+ T cells by increasing virus entry and establishing a more permissive environment to infection.
    J Virol. 2016 Dec 7. pii: JVI.01402.
    >> Share

  267. ROCHAT MA, Schlaepfer E, Speck RF
    Promising Role of Toll-Like Receptor 8 Agonist in Concert with Prostratin for Activation of Silent HIV.
    J Virol. 2016 Dec 7. pii: JVI.02084.
    >> Share

  268. ZOUBCHENOK D, Veillette M, Prevost J, Sanders-Buell E, et al
    Histidine 375 Modulates CD4 Binding in HIV-1 CRF01_AE Envelope Glycoproteins.
    J Virol. 2016 Dec 7. pii: JVI.02151.
    >> Share

  269. DIETRICH MH, Ogden KM, Katen SP, Reiss K, et al
    Structural Insights into Reovirus sigma1 Interactions with Two Neutralizing Antibodies.
    J Virol. 2016 Dec 7. pii: JVI.01621.
    >> Share

  270. SHAW JM, Miller-Novak LK, Mohanram V, McKinnon K, et al
    Influence of Plasma Cell Niche Factors on the Recruitment and Maintenance of IRF4hi Plasma Cells and Plasmablasts in Vaccinated, SIV-Infected Rhesus Macaques with Low and High Viremia.
    J Virol. 2016 Dec 7. pii: JVI.01727.
    >> Share

  271. BEITARI S, Ding S, Pan Q, Finzi A, et al
    The effect of HIV-1 Env on SERINC5 antagonism.
    J Virol. 2016 Dec 7. pii: JVI.02214.
    >> Share

  272. KASTURI SP, Kozlowski PA, Nakaya HI, Burger MC, et al
    Adjuvanting an SIV vaccine with TLR ligands encapsulated in nanoparticles induces persistent antibody responses and enhanced protection in TRIM5alpha restrictive macaques.
    J Virol. 2016 Dec 7. pii: JVI.01844.
    >> Share

    November 2016
  273. WETZEL KS, Yi Y, Elliott ST, Romero D, et al
    CXCR6-mediated SIVagmSab Entry into Sabaeus African Green Monkey Lymphocytes Implicates Widespread Use of Non-CCR5 Pathways in Natural Host Infections.
    J Virol. 2016 Nov 30. pii: JVI.01626.
    >> Share

  274. WANG L, Wang Y, Zhao J, Ren J, et al
    LUBAC modulates LMP1 activation of NFkappaB and IRF7.
    J Virol. 2016 Nov 30. pii: JVI.01138.
    >> Share

  275. MURAKOSHI H, Koyanagi M, Chikata T, Rahman MA, et al
    Accumulation of Pol mutations selected by HLA-B*52:01-C*12:02 protective haplotype-restricted CTLs causes low plasma viral load due to low viral fitness of mutant viruses.
    J Virol. 2016 Nov 30. pii: JVI.02082.
    >> Share

  276. YE C, Wang W, Cheng L, Li G, et al
    Glycosyl-phosphatidylinositol (GPI)-anchored anti-HIV scFv efficiently protect CD4 T cells from HIV-1 infection and deletion in hu-PBL mice.
    J Virol. 2016 Nov 23. pii: JVI.01389.
    >> Share

  277. WANG Y, Mao L, Kankanala J, Wang Z, et al
    Inhibition of Human Cytomegalovirus pUL89 Terminase Subunit Blocks Virus Replication and Genome Cleavage.
    J Virol. 2016 Nov 23. pii: JVI.02152.
    >> Share

  278. ARA A, Love RP, Follack TB, Ahmed KA, et al
    Mechanism of enhanced HIV restriction by virion coencapsidated cytidine deaminases APOBEC3F and APOBEC3G.
    J Virol. 2016 Nov 23. pii: JVI.02230.
    >> Share

  279. MADANI N, Princiotto AM, Zhao C, Jahanbakhshsefidi F, et al
    Activation and Inactivation of Primary Human Immunodeficiency Virus (HIV-1) Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
    J Virol. 2016 Nov 23. pii: JVI.01880.
    >> Share

  280. BEHRENS RT, Aligeti M, Pocock GM, Higgins CA, et al
    NES masking regulates HIV-1 Rev trafficking and viral RNA nuclear export.
    J Virol. 2016 Nov 16. pii: JVI.02107.
    >> Share

  281. LIU X, Happel C, Ziegelbauer JM
    KSHV microRNAs Target GADD45B to Protect Infected Cells from Cell Cycle Arrest and Apoptosis.
    J Virol. 2016 Nov 16. pii: JVI.02045.
    >> Share

  282. PINCUS SH, Song K, Maresh GA, Hamer DH, et al
    Identification of Human Anti-HIV gp160 Monoclonal Antibodies That Make Effective Immunotoxins.
    J Virol. 2016 Nov 16. pii: JVI.01955.
    >> Share

  283. WANG L, Eng ET, Law K, Gordon RE, et al
    Visualization of HIV T cell virological synapses and virus-containing compartments by 3D correlative light and electron microscopy.
    J Virol. 2016 Nov 9. pii: JVI.01605.
    >> Share

  284. BEHRENS AJ, Harvey DJ, Milne E, Cupo A, et al
    Molecular architecture of the cleavage-dependent mannose patch on a soluble HIV-1 envelope glycoprotein trimer.
    J Virol. 2016 Nov 2. pii: JVI.01894.
    >> Share

    October 2016
  285. WANG GZ, Goff SP
    Transcriptional Silencing of Moloney Murine Leukemia Virus in Human Embryonic Carcinoma Cells.
    J Virol. 2016 Oct 26. pii: JVI.02075.
    >> Share

  286. TAKAHATA T, Takeda E, Tobiume M, Tokunaga K, et al
    Critical Contribution of Tyr15 in the HIV-1 Integrase (IN) to Facilitate the IN Assembly and Non-enzymatic Function Through the IN Precursor Form with Reverse Transcriptase.
    J Virol. 2016 Oct 19. pii: JVI.02003.
    >> Share

  287. XIONG S, Borrego P, Ding X, Zhu Y, et al
    A Helical Short-Peptide Fusion Inhibitor with Highly Potent Activities against HIV-1, HIV-2 and Simian Immunodeficiency Virus.
    J Virol. 2016 Oct 19. pii: JVI.01839.
    >> Share

  288. LI C, Wang HB, Kuang WD, Ren XX, et al
    Naf1 regulates HIV-1 latency by suppressing viral promoter-driven gene expression in primary CD4+ T cells.
    J Virol. 2016 Oct 19. pii: JVI.01830.
    >> Share

  289. CHEESEMAN HM, Olejniczak NJ, Rogers PM, Evans AB, et al
    Broadly Neutralising Antibodies Display Superior Potential Over Non-Neutralising Antibodies in Preventing HIV-1 infection of Mucosal Tissue.
    J Virol. 2016 Oct 19. pii: JVI.01762.
    >> Share

  290. SU S, Zhu Y, Ye S, Qi Q, et al
    Creating an artificial tail-anchor as a novel strategy to enhance the potency of peptide-based HIV fusion inhibitors.
    J Virol. 2016 Oct 19. pii: JVI.01445.
    >> Share

  291. WAKEMAN BS, Izumiya Y, Speck SH
    Identification of novel KSHV Orf50 transcripts: discovery of new RTA isoforms with variable transactivation potential.
    J Virol. 2016 Oct 19. pii: JVI.01434.
    >> Share

  292. PINCUS SH, Song K, Maresh GA, Frank A, et al
    Design and In Vivo Characterization of Immunoconjugates Targeting HIV gp160.
    J Virol. 2016 Oct 19. pii: JVI.01360.
    >> Share

  293. COSS KP, Vasiljevic S, Pritchard LK, Krumm SA, et al
    HIV-1 glycan density drives the persistence of the mannose patch within an infected individual.
    J Virol. 2016 Oct 5. pii: JVI.01542.
    >> Share

  294. JIANG X, Totrov M, Li W, Sampson JM, et al
    Rationally Designed Immunogens Targeting HIV-1 gp120 V1V2 Induce Distinct Conformation-Specific Antibody Responses in Rabbits.
    J Virol. 2016 Oct 5. pii: JVI.01409.
    >> Share

  295. LI S, Folkvord JM, Rakasz EG, Abdelaal HM, et al
    SIV-producing cells in follicles are partially suppressed by CD8+ cells in vivo.
    J Virol. 2016 Oct 5. pii: JVI.01332.
    >> Share

    September 2016
  296. WU F, Kirmaier A, White E, Ourmanov I, et al
    TRIM5alpha Resistance Escape Mutations in Capsid are Transferable Between Simian Immunodeficiency Virus Strains.
    J Virol. 2016 Sep 28. pii: JVI.01620.
    >> Share

  297. CHEN CY, Shingai M, Welbourn S, Martin MA, et al
    Antagonism of BST-2/tetherin is a conserved function of the Env glycoprotein of primary HIV-2 isolates.
    J Virol. 2016 Sep 28. pii: JVI.01451.
    >> Share

  298. TRAUTZ B, Pierini V, Wombacher R, Stolp B, et al
    Antagonism of the SERINC5 Particle Infectivity Restriction by HIV-1 Nef Involves Counteraction of Virion-associated Pools of the Restriction Factor.
    J Virol. 2016 Sep 28. pii: JVI.01246.
    >> Share

  299. LACOMBE B, Morel M, Margottin-Goguet F, Ramirez BC, et al
    Specific inhibition of HIV infection by spironolactone in T cells.
    J Virol. 2016 Sep 28. pii: JVI.01722.
    >> Share

  300. EGGINK D, de Taeye SW, Bontjer I, Klasse PJ, et al
    HIV-1 escape from a peptidic anchor inhibitor by envelope glycoprotein spike stabilization.
    J Virol. 2016 Sep 21. pii: JVI.01616.
    >> Share

  301. LONGO NS, Sutton MS, Shiakolas AR, Guenaga J, et al
    Multiple antibody lineages in one donor target the glycan-V3 supersite of the HIV-1 envelope glycoprotein and display a preference for quaternary binding.
    J Virol. 2016 Sep 21. pii: JVI.01012.
    >> Share

  302. ARIAS JF, Colomer-Lluch M, von Bredow B, Greene JM, et al
    Tetherin Antagonism by HIV-1 Group M Nef Proteins.
    J Virol. 2016 Sep 21. pii: JVI.01465.
    >> Share

  303. LIU L, Wang W, Matz J, Ye C, et al
    Glycosyl Phosphatidylinositol-Anchored Variable Region of Llama Heavy Chain Only Antibody JM4 Efficiently Blocks Both Cell-Free and T Cell-T Cell Transmission of Human Immunodeficiency Virus Type 1.
    J Virol. 2016 Sep 21. pii: JVI.01559.
    >> Share

  304. DENG J, Mitsuki YY, Shen G, Ray J, et al
    HIV envelope gp120 alters T-cell receptor mobilization in the immunological synapse of uninfected CD4 T cells and augments the T cell activation.
    J Virol. 2016 Sep 14. pii: JVI.01532.
    >> Share

  305. GU Q, Zhang Z, Ortiz LC, Franco AC, et al
    FIV Vif N-Terminal Residues Selectively Counteract Feline APOBEC3s.
    J Virol. 2016 Sep 14. pii: JVI.01593.
    >> Share

  306. PINZONE MR, Graf E, Lynch L, McLaughlin B, et al
    Monitoring integration over time supports a role for CTL and ongoing replication as determinants of reservoir size.
    J Virol. 2016 Sep 14. pii: JVI.00242.
    >> Share

  307. ZOLLA-PAZNER S, Powell R, Yahyaei S, Williams C, et al
    J Virol. 2016 Sep 14. pii: JVI.01403.
    >> Share

  308. COSTA M, Pollara J, Edwards RW, Seaman M, et al
    Fc receptor mediated activities by Env-specific human mAbs generated from volunteers receiving the DNA prime-protein boost HIV vaccine DP6-001.
    J Virol. 2016 Sep 14. pii: JVI.01458.
    >> Share

  309. PRENTICE HA, Lu H, Price MA, Kamali A, et al
    Dynamics and Correlates of CD8 T-cell Counts in Africans with Primary Human Immunodeficient Virus Type I (HIV-1) Infection.
    J Virol. 2016 Sep 14. pii: JVI.01467.
    >> Share

  310. KEATING SM, Heitman JW, Wu S, Deng X, et al
    Magnitude and quality of cytokine and chemokine storm during acute infection distinguish non-progressive and progressive simian immunodeficiency virus infections of nonhuman primates.
    J Virol. 2016 Sep 14. pii: JVI.01061.
    >> Share

    August 2016
  311. BEGO MG, Cong L, Mack K, Kirchhoff F, et al
    Differential Control of BST2 restriction and Plasmacytoid Dendritic Cell Antiviral Response by Antagonists encoded by HIV-1 Group M and O Strains.
    J Virol. 2016 Aug 31. pii: JVI.01131.
    >> Share

  312. WIBMER CK, Gorman J, Anthony CS, Mkhize NN, et al
    Structure of an N276-dependent HIV-1 Neutralizing Antibody Targeting a Rare V5 Glycan Hole adjacent to the CD4 Binding Site.
    J Virol. 2016 Aug 31. pii: JVI.01357.
    >> Share

  313. ZHANG Z, Gu Q, Jaguva Vasudevan AA, Jeyaraj M, et al
    Vif Proteins from Diverse HIV/SIV Lineages have Distinct Binding Sites in A3C.
    J Virol. 2016 Aug 31. pii: JVI.01497.
    >> Share

  314. EBERHARDT MK, Deshpande A, Fike J, Short R, et al
    Exploitation of IL-10 Signaling Pathways: The Alternate Roles of Viral and Cellular IL-10 in Rhesus Cytomegalovirus Infection.
    J Virol. 2016 Aug 24. pii: JVI.00635.
    >> Share

  315. LA PORTE A, Cano J, Wu X, Mitra D, et al
    An essential role of INI1/hSNF5 chromatin remodeling protein in HIV-1 post-transcriptional events and Gag/GagPol stability.
    J Virol. 2016 Aug 24. pii: JVI.00323.
    >> Share

  316. AYALA VI, Trivett MT, Barsov EV, Jain S, et al
    Adoptive Transfer of Engineered Rhesus SIV-Specific CD8+ T Cells Reduces the Number of Transmitted/Founder Viruses Established in Rhesus Macaques.
    J Virol. 2016 Aug 24. pii: JVI.01522.
    >> Share

  317. LUND JM, Broliden K, Pyra MN, Thomas KK, et al
    HIV-1-neutralizing IgA is detected in genital secretions of highly HIV-1 exposed seronegative women on oral pre-exposure prophylaxis.
    J Virol. 2016 Aug 24. pii: JVI.01482.
    >> Share

  318. BARRETO-DE-SOUZA V, Arakelyan A, Zicari S, Margolis L, et al
    Monocytes but not lymphocytes carrying HIV-1 on their surface transmit infection to human tissue ex vivo.
    J Virol. 2016 Aug 24. pii: JVI.00742.
    >> Share

  319. STARLING S, Jolly C
    LFA-1 engagement triggers T cell polarization at the HIV-1 virological synapse.
    J Virol. 2016 Aug 24. pii: JVI.01152.
    >> Share

  320. LIU B, Zou F, Lu L, Chen C, et al
    CAR-T Cells Guided by the Single-Chain Fv of a Broadly Neutralizing Antibody Specifically and Effectively Eradicate the Reactivated Virus-latently-infected CD4+ T-lymphocytes Isolated from HIV-1-infected Individuals Receiving Suppressive cART.
    J Virol. 2016 Aug 17. pii: JVI.00852.
    >> Share

  321. DING S, Medjahed H, Prevost J, Coutu M, et al
    Lineage-specific differences in the gp120 Inner Domain Layer 3 of Human and Simian Immunodeficiency Viruses.
    J Virol. 2016 Aug 17. pii: JVI.01215.
    >> Share

  322. SCHMIEDEL D, Tai J, Levi-Schaffer F, Dovrat S, et al
    Human Herpesvirus 6 downregulates the expression of activating ligands during lytic infection to escape elimination by natural killer cells.
    J Virol. 2016 Aug 17. pii: JVI.01164.
    >> Share

  323. TRINITE B, Chan CN, Lee CS, Levy DN, et al
    Erratum for Trinite et al., HIV-1 Vpr- and Reverse Transcription-Induced Apoptosis in Resting Peripheral Blood CD4 T Cells and Protection by Common Gamma-Chain Cytokines.
    J Virol. 2016;90:7593.
    >> Share

  324. MWIMANZI P, Tietjen I, Miller SC, Shahid A, et al
    A novel acylguanidine-based inhibitor of HIV-1.
    J Virol. 2016 Aug 10. pii: JVI.01107.
    >> Share

  325. VERKERKE HP, Williams JA, Guttman M, Simonich CA, et al
    Epitope-independent purification of native-like envelope trimers from diverse HIV-1 isolates.
    J Virol. 2016 Aug 10. pii: JVI.01351.
    >> Share

  326. MANGHERA M, Ferguson-Parry J, Lin R, Douville RN, et al
    NF-kappaB and IRF1 Induce Endogenous Retrovirus-K Expression via Interferon-Stimulated Response Elements in its 5' Long Terminal Repeat.
    J Virol. 2016 Aug 10. pii: JVI.01503.
    >> Share

  327. LIANG Y, Guttman M, Williams JA, Verkerke H, et al
    Changes in structure and antigenicity of HIV-1 Env trimers resulting from removal of a conserved CD4 binding site-proximal glycan.
    J Virol. 2016 Aug 3. pii: JVI.01116.
    >> Share

    July 2016
  328. LAMERS SL, Rose R, Maidji E, Agsalda-Garcia M, et al
    HIV DNA is frequently present within pathologic tissues evaluated at autopsy from cART-treated patients with undetectable viral load.
    J Virol. 2016 Jul 27. pii: JVI.00674.
    >> Share

  329. ROSE R, Lamers SL, Nolan DJ, Maidji E, et al
    HIV maintains an evolving and dispersed population among multiple tissues during suppressive cART with periods of rapid expansion corresponding to the onset of cancer.
    J Virol. 2016 Jul 27. pii: JVI.00684.
    >> Share

  330. MARTRUS G, Niehrs A, Cornelis R, Rechtien A, et al
    Kinetics of HIV-1 latency reversal quantified on the single cell level using a novel flow-based technique.
    J Virol. 2016 Jul 27. pii: JVI.01448.
    >> Share

  331. DONIUS LR, Cheng Y, Choi J, Sun ZJ, et al
    Generation of long-lived bone marrow plasma cells secreting antibodies specific for HIV-1 gp41 MPER in the absence of polyreactivity.
    J Virol. 2016 Jul 27. pii: JVI.01089.
    >> Share

  332. HIMES JE, Ho C, Nguyen Q, Amos JD, et al
    Characterization of anatomically compartmentalized plasma and milk simian immunodeficiency virus variants in chronically infected African green monkeys.
    J Virol. 2016 Jul 27. pii: JVI.00701.
    >> Share

  333. IYER SS, Gangadhara S, Victor B, Shen X, et al
    Virus-like particles displaying trimeric SIV envelope gp160 enhance the breadth of DNA/MVA SIV vaccine induced antibody responses in rhesus macaques.
    J Virol. 2016 Jul 27. pii: JVI.01163.
    >> Share

  334. RUCEVIC M, Kourjian G, Boucau J, Blatnik R, et al
    MHC-bound HIV Peptides Identified from Various Cell Types Reveal Common Nested Peptides and Novel T Cell Responses.
    J Virol. 2016 Jul 20. pii: JVI.00599.
    >> Share

  335. YAN Q, Shen C, Qin J, Li W, et al
    HIV-1 Vpr Inhibits Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication by Inducing MiR-942-5p and Activating NF-kappaB Signaling.
    J Virol. 2016 Jul 20. pii: JVI.00797.
    >> Share

  336. TOWNSLEY S, Mohamed Z, Guo W, McKenna J, et al
    Induction of heterologous Tier 2 HIV-1 neutralizing and cross-reactive V1/V2-specific antibodies in rabbits by prime-boost immunization.
    J Virol. 2016 Jul 20. pii: JVI.00853.
    >> Share

  337. INLORA J, Chukkapalli V, Bedi S, Ono A, et al
    The molecular determinants directing HIV-1 Gag assembly to the virus-containing compartments in primary macrophages.
    J Virol. 2016 Jul 20. pii: JVI.01004.
    >> Share

  338. JIMENEZ E, Ruiz A, Kloverpris HN, Rodriguez-Plata MT, et al
    Non-human TRIM5 variants enhance recognition of HIV-1-infected cells by CD8+ T cells.
    J Virol. 2016 Jul 20. pii: JVI.00819.
    >> Share

  339. DI SCALA M, Otano I, Gil-Farina I, Vanrell L, et al
    Complementary effects of IL-15 and IFN-alpha induce immunity in HBV transgenic mice.
    J Virol. 2016 Jul 20. pii: JVI.01030.
    >> Share

  340. GACH JS, Venzon D, Vaccari M, Keele BF, et al
    The relationship between vaccine-induced antibody capture of infectious virus and infection outcomes following low-dose, repeated rectal challenge with SIVmac251.
    J Virol. 2016 Jul 20. pii: JVI.00812.
    >> Share

  341. LOPKER MJ, Del Prete GQ, Estes JD, Li H, et al
    Derivation and characterization of pathogenic transmitted/founder molecular clones from SIVsmE660 and SIVmac251 following mucosal infection.
    J Virol. 2016 Jul 13. pii: JVI.00718.
    >> Share

  342. MURGATROYD C, Pirrie L, Tran F, Smith TK, et al
    Structure-activity relationships of the Human Immunodeficiency Virus Type 1 maturation inhibitor PF-46396.
    J Virol. 2016 Jul 6. pii: JVI.01075.
    >> Share

  343. GRAF T, Fritsch HM, de Medeiros RM, Junqueira DM, et al
    Comprehensive characterization of the HIV-1 molecular epidemiology and demographic history in the Brazilian region most heavily affected by AIDS.
    J Virol. 2016 Jul 6. pii: JVI.00363.
    >> Share

  344. CHACHAGE M, Pollakis G, Kuffour EO, Haase K, et al
    CD25+FoxP3+ memory CD4 T cells are frequent targets of HIV infection in vivo.
    J Virol. 2016 Jul 6. pii: JVI.00612.
    >> Share

  345. DING S, Tolbert WD, Prevost J, Pacheco B, et al
    A Highly Conserved gp120 Inner Domain Residue Modulates Env Conformation and Trimer Stability.
    J Virol. 2016 Jul 6. pii: JVI.01068.
    >> Share

    June 2016
  346. MARTIN JL, Cao S, Maldonado JO, Zhang W, et al
    Distinct particle morphologies revealed through comparative parallel analyses of retrovirus-like particles.
    J Virol. 2016 Jun 29. pii: JVI.00666.
    >> Share

  347. MURRELL B, Vollbrecht T, Guatelli J, Wertheim JO, et al
    The Evolutionary Histories of Antiretroviral Proteins SERINC3 and SERINC5 Do Not Support an Evolutionary Arms Race in Primates.
    J Virol. 2016 Jun 29. pii: JVI.00972.
    >> Share

  348. ZERBATO JM, Serrao E, Lenzi G, Kim B, et al
    Establishment and Reversal of HIV-1 Latency in Naive and Central Memory CD4+ T Cells in Vitro.
    J Virol. 2016 Jun 29. pii: JVI.00553.
    >> Share

  349. DAGENAIS-LUSSIER X, Aounallah M, Mehraj V, El-Far M, et al
    Kynurenine Reduces Memory CD4 T-cell Survival by Interfering with IL-2 Signaling early During HIV-1 Infection.
    J Virol. 2016 Jun 29. pii: JVI.00994.
    >> Share

  350. CHRISTENSEN-QUICK A, Lafferty M, Sun L, Marchionni L, et al
    Human Th17 cells lack HIV-inhibitory RNases and are highly permissive to productive HIV infection.
    J Virol. 2016 Jun 22. pii: JVI.02869.
    >> Share

  351. GARDNER MR, Fellinger CH, Prasad NR, Zhou AS, et al
    CD4-induced antibodies promote association of the HIV-1 envelope glycoprotein with CD4-binding site antibodies.
    J Virol. 2016 Jun 22. pii: JVI.00803.
    >> Share

  352. DUTARTRE H, Claviere M, Journo C, Mahieux R, et al
    Cell-free versus cell-to-cell infection by HIV-1 and HTLV-1: exploring the link among viral source, viral trafficking and viral replication.
    J Virol. 2016 Jun 22. pii: JVI.00407.
    >> Share

  353. DINAPOLI SR, Hirsch VM, Brenchley JM
    Macrophages in progressive HIV/SIV infections.
    J Virol. 2016 Jun 15. pii: JVI.00672.
    >> Share

  354. YUAN Z, Kang G, Ma F, Lu W, et al
    Recapitulating Cross-Species Transmission of SIVcpz to Humans Using Humanized-BLT Mice.
    J Virol. 2016 Jun 15. pii: JVI.00860.
    >> Share

  355. SAITO A, Henning MS, Serrao E, Dubose BN, et al
    The capsid-CPSF6 interaction is dispensable for HIV-1 replication in primary cells but is selected during virus passage in vivo.
    J Virol. 2016 Jun 15. pii: JVI.00019.
    >> Share

  356. TRAN EE, Nelson EA, Bonagiri P, Simmons JA, et al
    Mapping of Ebolavirus Neutralization by Monoclonal Antibodies in the ZMapp Cocktail Using Cryo-Electron Tomography and Studies of Cellular Entry.
    J Virol. 2016 Jun 8. pii: JVI.00406.
    >> Share

  357. SCHOMMERS P, Martrus G, Matschl U, Sirignano M, et al
    Changes in HIV-1 Capsid stability induced by common CTL-driven viral sequence mutations.
    J Virol. 2016 Jun 8. pii: JVI.00867.
    >> Share

  358. CALASCIBETTA F, Micci L, Carnathan D, Lawson B, et al
    Antiretroviral therapy in SIV-infected sooty mangabeys: implications for AIDS pathogenesis.
    J Virol. 2016 Jun 8. pii: JVI.00598.
    >> Share

  359. BULLI L, Apolonia L, Kutzner J, Pollpeter D, et al
    Complex interplay between HIV-1 Capsid and MX2-independent IFNalpha-induced antiviral factors.
    J Virol. 2016 Jun 8. pii: JVI.00458.
    >> Share

  360. JENSEN K, Nabi R, Van Rompay KK, Robichaux S, et al
    Vaccine-elicited mucosal and systemic antibody responses are associated with reduced simian immunodeficiency viremia in infant rhesus macaques.
    J Virol. 2016 Jun 1. pii: JVI.00481.
    >> Share

    May 2016
  361. ZHOU S, Bednar MM, Sturdevant CB, Hauser BM, et al
    Deep Sequencing of the HIV-1 env Gene Reveals Discrete X4 Lineages and Linkage Disequilibrium Between X4 and R5 Viruses In the V1/V2 and V3 Variable Regions.
    J Virol. 2016 May 25. pii: JVI.00441.
    >> Share

  362. GADHAMSETTY S, Coorens T, de Boer RJ
    Notwithstanding circumstantial alibis, cytotoxic T cells can be major killers of HIV-1 infected cells.
    J Virol. 2016 May 25. pii: JVI.00306.
    >> Share

  363. ALI A, Kitchen SG, Chen IS, Ng HL, et al
    HIV-1-Specific Chimeric Antigen Receptors Based on Broadly-Neutralizing Antibodies.
    J Virol. 2016 May 25. pii: JVI.00805.
    >> Share

  364. VERMA A, Rajagopalan P, Lotke R, Varghese R, et al
    Functional incompatibility between the generic NF-kappaB motif and a subtype-specific Sp1III element drives the formation of HIV-1 subtype C viral promoter.
    J Virol. 2016 May 18. pii: JVI.00308.
    >> Share

  365. GARCIA-MIRANDA P, Becker JT, Benner BE, Blume A, et al
    HIV frameshift site RNA stability correlates with frameshift efficiency and decreased viral infectivity.
    J Virol. 2016 May 18. pii: JVI.00149.
    >> Share

  366. KOOFHETHILE CK, Ndhlovu ZM, Thobakgale-Tshabalala C, Prado JG, et al
    CD8+ T cell breadth and ex vivo virus inhibition capacity distinguish between viremic controllers with and without protective HLA class I alleles.
    J Virol. 2016 May 18. pii: JVI.00276.
    >> Share

  367. BAILEY AL, Lauck M, Ghai RR, Nelson CW, et al
    Arteriviruses, pegiviruses, and lentiviruses are common among wild African monkeys.
    J Virol. 2016 May 11. pii: JVI.00573.
    >> Share

  368. PUJOL FM, Laketa V, Schmidt F, Mukenhirn M, et al
    HIV-1 Vpu Antagonizes CD317/tetherin by Adaptor protein-1-Mediated Exclusion from Virus Assembly Sites.
    J Virol. 2016 May 11. pii: JVI.00504.
    >> Share

  369. CARTWRIGHT EK, Palesch D, Mavigner M, Paiardini M, et al
    Initiation of antiretroviral therapy restores CD4+ TSCM homeostasis in SIV-infected macaques.
    J Virol. 2016 May 11. pii: JVI.00492.
    >> Share

  370. GARDINER JC, Mauer EJ, Sherer NM
    HIV-1 Gag, Envelope, and extracellular determinants cooperate to regulate the stability and turnover of virological synapses.
    J Virol. 2016 May 11. pii: JVI.00600.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016